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Abstract	  
Many important biological functions of glycosaminoglycans (GAGs) have been 
highlighted in research literature during recent years. GAGs often serve as function-
bearing structural elements in the extracellular matrix (ECM), but are also 
constituents of the cell membrane. GAGs take part in various biological mechanisms, 
e.g. regulating tissue growth and maintenance, as well as in the development of 
different diseases. The varying chemical structure of GAGs promotes interesting 
properties, but also makes them challenging to study. Surface-based analytical 
techniques can provide detailed information about the many interactions that GAGs 
participate in. This requires immobilization of one of the interacting entities in a 
biofunctional manner to ensure reliability of the subsequent interaction studies. 
 
In this thesis, different methods for immobilizing GAGs to surfaces were investigated 
with the aim of studying GAG-related interactions. The GAGs chondroitin sulfate 
(CS) and hyaluronan (HA), as well as synthetically sulfated derivatives were 
primarily used. Immobilization was made to supported lipid bilayers on silica and 
self-assembled monolayers on gold, either using native GAGs or variants 
functionalized with e.g. biotin. The formation of GAG-based layer-by-layer 
assemblies was also studied. Immobilization and subsequent interactions were 
followed in real-time using quartz crystal microbalance with dissipation monitoring 
(QCM-D) and surface plasmon resonance (SPR)-based sensing. Interaction studies 
with various biological entities were made. The interactions were highly dependent on 
the orientation of the GAGs on the surface, and pros and cons associated with side-on 
versus end-on immobilization are discussed in the thesis. The immobilization strategy, 
especially if functional groups were introduced on the GAG, also influenced how the 
GAG was recognized by an interacting protein. Further, sulfated GAGs are known to 
serve as attachment factors for certain viruses, and binding studies of a herpes simplex 
virus glycoprotein to immobilized GAGs revealed interesting characteristics of certain 
regions on the protein. Also the initial effect of chondrocytes on immobilized HA was 
studied using combined surface sensing and light microscopy. The results presented 
here emphasize important aspects to consider when designing GAG-based interaction 
platforms, and exemplifies important biological studies that can be made by utilizing 
such platforms.  
 
Keywords: glycosaminoglycans, surface immobilization, interaction studies, growth 
factor, virus glycoprotein, QCM-D, SPR 
 IV 
  	  
  V 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gabriel. Be curious. Be wise. Be happy. 
 	  
 VI 
Appended	  Papers	  
Paper	  I	  
 
Immobilization of Chondroitin Sulfate to Lipid Membranes and its Interactions 
with ECM Proteins 
Noomi Altgärde, Jana Becher, Stephanie Möller, Franz E. Weber, Matthias 
Schnabelrauch, Sofia Svedhem 
Journal of Colloid and Interface Science 390 (2013) 258–266 
 
I was responsible for designing and planning the experimental work. I performed all 
the experiments concerning GAG-immobilization and protein interactions. I wrote the 
main part of the manuscript.  
 
Paper	  II	  
 
Probing the biofunctionality of biotinylated hyaluronan and chondroitin sulfate 
by hyaluronidase degradation and aggrecan interaction 
Noomi Altgärde,† Erik Nilebäck,† Laura De Battice, Jana Becher, Stephanie Möller, 
Matthias Schnabelrauch, Sofia Svedhem 
†Authors contributed equally 
Acta Biomaterialia 9 (2013) 8158–8166 
 
I was, together with E.N., responsible for designing and planning the experimental 
work. I performed the experiments concerning immobilization of GAGs for 
interaction studies using aggrecan, as well as additional physico-chemical 
characterization of the GAG layers. I wrote the main part of the manuscript. 
 
Paper	  III	  
 
Mucin-like region of herpes simplex virus type 1 attachment protein gC 
modulates the virus-glycosaminoglycan interaction 
Noomi Altgärde, Charlotta Eriksson, Edward Trybala, Stephanie Moeller, Matthias 
Schnabelrauch, Sofia Svedhem, Tomas Bergström, Marta Bally 
In manuscript (2014)  
 
I was, together with M.B., responsible for planning and performing the experimental 
work regarding the gC-GAG interaction studies. I wrote the main part of the 
manuscript. 
  
  VII 
Paper	  IV	  
 
Acoustic monitoring of changes in well-defined hyaluronan layers exposed to 
chondrocytes 
Erik Nilebäck, Lars Enochson, Noomi Altgärde, Matthias Schnabelrauch, Anders 
Lindahl, Sofia Svedhem, Angelika Kunze 
Analyst 139 (2014) 5350-5353  
 
I participated in designing and performing the experiments, and proofreading of the 
manuscript. 
 
Paper	  V	  
 
Tuning Cell Adhesion and Growth on Biomimetic Polyelectrolyte Multilayers by 
Variation of pH During Layer-by-Layer Assembly 
Neha Aggarwal, Noomi Altgärde, Sofia Svedhem, Georgios Michanetzis, Yannis 
Missirlis, Thomas Groth 
Macromolecular Bioscience 13 (2013) 1327–1338 
 
I took part in the QCM-D measurements and especially in the interpretation of the 
data. I was involved in writing the manuscript, particularly concerning QCM-D.  
 
  
 VIII 
Papers	  not	  included	  in	  the	  thesis	  
Effect of Molecular Composition of Heparin and Cellulose Sulfate on Multilayer 
Formation and Cell Response 
Neha Aggarwal, Noomi Altgärde, Sofia Svedhem, Kai Zhang, Steffen Fischer, 
Thomas Groth  
Langmuir 29 (2013) 13853-13864 
 
Peptide-membrane interactions of arginine-tryptophan peptides probed using 
quartz crystal microbalance with dissipation monitoring 
Hanna Rydberg, Angelika Kunze, Nils Carlsson, Noomi Altgärde, Sofia Svedhem, 
Bengt Nordén 
European Biophysics Journal 43 (2014) 241-253 
 
Study on multilayer structures prepared from heparin and semi-synthetic 
cellulose sulfates as polyanions and their influence on cellular response 
Neha Aggarwal, Noomi Altgärde, Sofia Svedhem, Kai Zhang, Steffen Fischer, 
Thomas Groth  
Colloids and Surfaces B: Biointerfaces 116 (2014) 93–103 
  
  IX 
Abbreviations	  
BMP-2: bone morphogenetic protein-2 
CS: chondroitin sulfate 
DS: dermatan sulfate 
ECM: extracellular matrix  
EDC: N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
GAG: glycosaminoglycan 
gC: glycoprotein 
HA: hyaluronan, hyaluronic acid, hyaluronate  
HS: heparan sulfate  
HSV: herpes simplex virus 
LbL: layer-by-layer 
NHS: N-hydroxysuccinimide 
SA: streptavidin 
SAM: self-assembled monolayer 
sHA: sulfated hyaluronan 
SLB: supported lipid bilayer 
SPR: surface plasmon resonance 
QCM-D: quartz crystal microbalance with dissipation monitoring 
 
  
 X 
Table	  of	  Contents	  
1	  Introduction	   1	  1.1	   Aim	   2	  
2	  Structure	  of	  glycosaminoglycans	   3	  2.1	   The	  importance	  of	  sulfation	   5	  2.2	   Synthetic	  modifications	   5	  
3	  Function	  and	  utilization	  of	  glycosaminoglycans	   7	  3.1	   Anticoagulants	   8	  3.2	   Tissue	  maintenance	   9	  3.2.1	   In	  vivo	  structural	  support	   9	  3.2.2	   Involvement	  in	  cancer	  progression	   9	  3.2.3	   Regulation	  of	  growth	  factor	  signaling	   10	  3.2.4	   Components	  in	  cell	  scaffolds	   10	  3.3	   Attachment	  factors	  for	  microbial	  pathogens	   11	  
4	  Designing	  glycosaminoglycan-­‐presenting	  surfaces	   13	  4.1	   Inert	  backgrounds	   13	  4.1.1	   Supported	  Lipid	  Bilayers	   13	  4.1.2	   Self-­‐Assembled	  Monolayers	   15	  4.2	   Immobilizing	  biomolecules	   15	  4.2.1	   Introducing	  functional	  groups	   15	  4.2.2	   Covalent	  coupling	   16	  4.2.3	   Biotin-­‐avidin	  binding	   17	  4.2.4	   Molecular	  adsorption	  and	  the	  layer-­‐by-­‐layer	  technique	   18	  
5	  Studying	  glycosaminoglycan	  interactions	   19	  5.1	   Specificity	   19	  5.2	   Multivalency	   20	  5.3	   Quantifying	  binding	  characteristics	   20	  
6	  Experimental	  techniques	   23	  6.1	   Quartz	  Crystal	  Microbalance	  with	  Dissipation	  Monitoring	   23	  6.1.1	   Modeling	  of	  QCM-­‐D	  data	   24	  6.2	   Surface	  Plasmon	  Resonance	   26	  6.3	   Fluorescence	  Recovery	  After	  Photobleaching	   28	  6.4	   Isoelectric	  point	  analysis	   28	  6.5	   Contact	  angle	  goniometry	   29	  
7	  Results	   31	  7.1	   Summary	  of	  appended	  papers	   31	  7.2	   Glycosaminoglycan	  library	   32	  7.3	   Strategies	  to	  immobilize	  glycosaminoglycans	   33	  7.3.1	   Covalent	  immobilization	  to	  supported	  lipid	  bilayers	  (Paper	  I)	   33	  7.3.2	   Immobilization	  via	  biotin-­‐streptavidin	  on	  self-­‐assembled	  monolayers	  	  	   (Paper	  II-­‐IV)	   36	  7.3.3	   Build-­‐up	  of	  layer-­‐by-­‐layer	  structures	  (Paper	  V)	   39	  7.4	   Biofunctionality	  of	  immobilized	  glycosaminoglycans	   40	  
  XI 
7.4.1	   Influence	  of	  introduced	  functional	  groups	  (Paper	  I	  &	  II)	   40	  7.4.2	   Side-­‐on	  vs.	  end-­‐on	  immobilization	  (Paper	  II,	  additional	  results)	   43	  7.5	   Biological	  applications	  of	  surface	  immobilized	  glycosaminoglycans	   46	  7.5.1	   Binding	  of	  herpes	  simplex	  virus	  glycoprotein	  C	  (Paper	  III)	   46	  7.5.2	   Initial	  effect	  of	  chondrocytes	  (Paper	  IV)	   49	  7.5.3	   Interactions	  with	  bone	  morphogenetic	  protein	  2	  (additional	  results)	   51	  
8	  Perspectives	  and	  outlook	   53	  
9	  Acknowledgements	   57	  	  
  
 XII 
 
  1 
 
1	  
Introduction	  
Medical discoveries are ever evolving. They shed light on the complex mechanisms 
that can keep a human alive for a hundred years, increase the understanding of how 
diseases begin and development, and lead to new strategies to replace or improve lost 
or impaired functions. Often, these advances rely on developments in scientific areas 
other than medical science, such as imaging, bioinformatics, material science and 
sensor science.  
 
To understand important functions at the organism level, detailed understanding of 
molecular mechanisms is key. In general, biomolecular studies can be divided into 
three major areas; genomics, studying the genetic material, proteomics involving 
studies of the proteins encoded in the genes, and glycomics, focusing on 
carbohydrates. Human genes have four building blocks, or nucleobases. A 
combination of three nucleobases, codes for one out of 20 amino acids, which in turn 
build up proteins. Carbohydrates, e.g., glycosaminoglycans (GAGs) that are the focus 
for this thesis, are not synthesized based on genetic templates, but consist of 
disaccharides built up from enzymatic reactions. The possible combinations of the 
different disaccharides are vast, making them highly diverse in both structure 
(Chapter 2) and function (Chapter 3).1,2 
 
The function of a certain molecule for an organism becomes evident when the 
molecule is missing or when its level is altered, e.g., due to a disease. The basis of this 
function lies in the existence of numerous interaction patterns between the molecule 
and other entities in the body. Controlled studies of these interactions can give a more 
detailed understanding of the complex mechanisms in our body. Due to their obvious 
importance, genomics and proteomics have for long been the primary focus when 
studying biomolecular interactions, and GAGs have mainly been prescribed to have 
structural properties in the tissue. However, likely owing to their strategic in vivo 
location, GAG-related interaction are expected to be involved in many vital 
mechanisms in the human body (Chapter 3).2,3 
 
Hitherto, interactions between GAGs and other biomolecules have been mostly 
studied using e.g., equilibrium dialysis, nuclear magnetic resonance (NMR), and 
isothermal titration calorimetry,3 studies through which invaluable insights about the 
interactions that GAGs take part in have been gained. All of these are examples of 
solution-based techniques, where the interacting partners can move freely in a 
solution. In vivo, GAGs are mostly found attached to a protein core and/or to the cell 
membrane and in that sense not moving freely. Hence, it could be beneficial to study 
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GAG-related interactions having the GAG immobilized to a surface, which also 
allows the use of surface-based techniques (Chapter 6). Apart from mimicking the in 
vivo environment for a particular system, there are other general benefits with using a 
surface-based approach when studying biomolecular interactions. Perhaps most 
notably, the connection of surface-based techniques with different transducer 
elements based on e.g., mechanical, optical, or electrical phenomena, allows for 
various types of information to be gained, often in real-time. The sample consumption 
is often lower and regeneration of the surface can allow for analysis of multiple 
samples on the same surface. Also, surface-based techniques allow for the 
development of biosensors for fast diagnostic applications.4,5 
 
Although surface-based analytical techniques can have many benefits, the 
requirement of immobilization can sometimes pose problems as it might disturb the 
natural functions of the immobilized biomolecule, or in other ways affect the studied 
interactions. Hence, a suitable surface and immobilization strategy has to be used to 
ensure that the generated information has biological significance (Chapter 4). Various 
methods can be used to reduce non-specific binding to the background. Supported 
lipid bilayers (SLBs) and self-assembled monolayers (SAMs) are examples of such 
surface modifications, which can be further functionalized to allow for 
immobilization of biomolecules via various chemistries. 
 
Apart from a better understanding of biological processes, the insights gained from 
studying GAG-related interactions can contribute to medical discoveries with 
applications both in vivo, e.g., as new drugs, and in vitro, e.g., as cell culture surfaces 
and tissue scaffolds, with the possibility of improving the quality of life. 
1.1 Aim	  
The aim of this thesis project has been to study GAG-related interactions using 
surface-based analytical techniques. It can be divided into two parts: i) evaluating 
different strategies for surface immobilization of GAGs compatible with common 
transducer substrates such as gold and silica. (Paper I, II, V), ii) utilizing the 
established surface platforms to study biologically relevant interactions with proteins 
and cells by monitoring optical and viscoelastic properties at the transducer interface 
(Paper III, IV). 
  3 
2	  
Structure	  of	  glycosaminoglycans	  
The molecular structure of GAGs in vivo, as well as synthetic modifications that can 
be made to GAGs in vitro, are discussion in this chapter. 
 
Glycosaminoglycans (GAGs) are long, unbranched polysaccharide chains consisting 
of repeated disaccharide units. One unit consists of two monosaccharides, one uronic 
sugar, containing a carboxyl group (with the exception of keratin sulfate) and one 
amino sugar, linked together by a glycosidic bond. The GAG chain has a structural 
direction by having a reducing and a non-reducing end (Table 1). 
 
All GAGs except hyaluronan (HA) are found attached to a protein core, forming a 
proteoglycan. Proteoglycans are synthesized by most vertebrate cells and extend from 
the cell membrane or are secreted into the extracellular matrix (ECM).1 The 
attachment of the GAG to the core protein begins in the endoplasmic reticulum and 
continues through the Golgi apparatus.6 The GAG grows via its non-reducing end and 
is attached via the reducing end to the proteoglycan.7 GAGs are also sulfated by 
sulfotransferases, creating a highly varying structure. The sulfation varies both in 
extent and placements on the saccharide, even within a certain GAG (section 2.1).6,8 
There are regions on the GAG chain displaying higher or lower (or no) sulfation, 
particularly prominent in heparan sulfate (HS). Other factors increasing the structural 
diversity of GAGs are the type of glycosidic bond, isomeric forms, and molecular 
weight.2 
 
The GAG HA is neither sulfated, nor connected to a protein core. In contrast to GAGs 
that are part of a proteoglycan, HA grows from its reducing end. It is synthesized by 
the membrane-associated enzyme hyaluronan synthase and transported into the ECM 
as its being produced. When synthesized, it can either stay connected to the 
membrane via association with the synthase, or be released into the ECM.9 
 
Interactions with enzymes, e.g., heparinases, chondroitinases, and hyaluronidase, 
depolymerize GAGs, regulating the amount of GAGs in the tissue.2,10  
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Table 1: Molecular structure and related specifics of glycosaminoglycans. 3,11-13  
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2.1 The	  importance	  of	  sulfation	  	  
GAG-related interactions are controlled to a large extent by the sulfation pattern of 
the GAG, e.g. evident as mutations resulting in the lack of sulfation cause severe 
developmental disorders.14 The different sulfation patterns seen in GAGs have been 
shown to be specific for certain tissues, developmental stages and disease 
conditions.1,15-18 HS, CS and DS all show a great diversity in their sulfation patterns, 
which is likely the reason why they have such multitude of functions. Considering the 
possible sulfation patterns listed in Table 1, HS can display 48 unique disaccharide 
blocks. This can be compared to DNA being built up by 4 unique nucleic acids, and 
proteins consisting of combinations of 20 different amino acids.2 Sulfation is made 
during proteoglycan synthesis but sulfation of the C6 position can also be 
post-synthetically removed by the enzymes Sulf1 and Sulf2, which either inhibits or 
activates certain functions.14 This plays a role in e.g. the binding of growth factors by 
HS (section 3.2.1),14,19 and is a good example of how sulfation can fine-tune the 
function of GAGs. 
2.2 Synthetic	  modifications	  
The structural diversity seen in GAGs makes them intriguing, but also challenging to 
study. GAGs isolated from animal and bacterial sources show great variability 
between batches, which sometimes results in difficulties when reproducing scientific 
findings. One approach to overcome such issues is to modify simpler GAGs or other 
polysaccharides to create GAG-derivatives or analogues. For example, cellulose that 
can be found in the cell wall of green plants consists of repeated units of the 
monosaccharide glucose. Chitin consists of N-glycosamine and N-acetyl-glucosamine 
units and can be extracted from e.g., crustaceans or fungi.20,21 These polysaccharides 
can be modified by e.g., acetylation22 and deacetylation,20 carboxymethylation,23 and 
sulfation24-26 in order to function as GAG-analogues or to enhance some GAG-related 
properties, e.g., loading of growth factors27. Enzymatic changes can also be applied to 
native GAGs; in thesis work, HA was used as a starting material in producing sulfated 
GAGs by reaction with a SO3-DMF (dimethylformamide) complex. The same 
strategy was also used to produce over-sulfated version of CS.28,29 
 
However, when using animal sources for the extraction of GAGs, there is a risk of 
contamination. For example, immunogenic proteins or infectious entities like viruses 
that are associated with the GAG could be extracted as well. Also, the difference in 
availability of different GAGs, albeit their similar molecular structure, has led to 
incidents of willful contamination. During the Chinese heparin crisis in 2008, natural 
heparin for the use as an anticoagulant drug, was partially replaced by synthetically 
over-sulfated CS, resulting in numerous deceased patients.30 The alternative to 
isolation from natural sources and chemical modification is to synthesize GAGs de 
novo. The structural complexity of GAGs and the need for protection and de-
protection of multiple orthogonal chemical groups make conventional methods 
STRUCTURE OF GAGS 
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suitable for the build-up of penta- and hexasaccharides only.31,32 Another possible 
strategy to synthesize GAGs is by the use of enzymatic reactions.31 
 
  7 
3	  
Function	  and	  utilization	  of	  
glycosaminoglycans	  	  
Even when the significance and/or the mechanisms of a certain GAG-related function 
is difficult to establish in vivo, GAGs can serve important functions in vitro or when 
administered as a drug. In this chapter, some examples of the various functions that 
GAGs can serve in vivo and in vitro are presented. 
 
 
Figure 1. Examples of the various functions of GAGs in the extracellular matrix (ECM) and at 
the cell membrane. Hyaluronan (HA) extends from the surface of many cells, either via its 
synthase or via the receptor CD44, forming a glycocalyx. HA can also be found free in the 
ECM where it, in e.g. cartilage, forms larger supramolecular structures together with the 
proteoglycan aggrecan, carrying numerous keratin sulfate (KS) and chondroitin sulfate (CS) 
chains. Aggrecan also interacts with collagen fibrils. Chondroitin sulfate (CS) and heparan 
sulfate (HS) at the cell membrane serve as attachment factors for e.g. viruses and growth 
factors. Enzymes in the ECM, e.g. hyaluronidase can degrade GAGs. (Note that the figure is 
not a representative of a certain tissue, but exemplifies different GAG functions.)  
HA
CS
KS
HS
collagen
aggrecan
CD44
growth 
factors
virus
ECM
cell cytoplasm
syndecan
hyaluronidase
HA synthase
growth factor 
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3.1 Anticoagulants	  
Blood coagulation involves multiple molecular interactions that finally lead to the 
formation of a blood clot (thrombus), consisting of fibrin and platelets (thrombocytes). 
This cascade of interactions is regulated by many different proteins that either activate 
or inhibit coagulation (Figure 2). Precise control is crucial as both an inactive and an 
overactive coagulation can be life threatening.33 In the early 20th century, the GAG 
heparin was found to have anticoagulant properties, and the mechanism was later 
confirmed to be through potentiation of the coagulation inhibiting enzymes 
antithrombin III and heparin cofactor II (Figure 2).34 The first heparin drug was 
commercialized in the 1940s but since the action of heparin was ascribed to a specific 
pentasaccharide sequence,35 it is today prescribed as depolymerized heparin 
(Fragmin®) or as a synthetic derivative of this pentasaccharide (Arixtra®).36 DS, and 
to some extent CS-E (Table 1) has been shown to have similar abilities as heparin to 
activate heparin cofactor II.37,38 
 
HA has no known heparin-like function on the coagulation cascade, likely due to the 
lack of sulfate groups.39 However, HA-based surface coatings have been shown to 
have antifouling properties by limiting the adsorption of plasma protein and 
subsequent adhesion of platelets, thereby inhibiting the initiation of blood 
coagulation.40-42 This is likely due to the masking of an otherwise thrombotic surface, 
and to the hydrophilic character of HA. This could potentially be utilized for coating 
of coronary stents, as stent-induced thrombosis is a major clinical problem.43 
 
Figure 2. Simplified schematic of the intrinsic and extrinsic pathways of the coagulation 
cascade. Heparin/HS inhibits coagulation by enhancing the activity of the inhibitors 
antithrombin III and heparin cofactor II. 
XII XIIa
XI XIa
IX IXa
XaX X
VIIVIIa
tissue factor
damaged
blood vessel
prothrombin thrombin
fibrin fibrinogen
thrombus
XIIIXIIIa
antithrombin III
heparin cofactor II
blood cells
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V
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charged surface
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3.2 Tissue	  maintenance	  
3.2.1 In	  vivo	  structural	  support	  
GAGs are major constituents of the ECM where it can interact with other GAGs and 
ECM proteins, forming extensive supramolecular assemblies around the cells. As an 
example, the proteoglycan aggrecan with multiple CS and KS chains, binds via the N-
terminal of the core protein to HA chains, together with a link protein (Figure 1).44 
This complex can in turn associate with the cell membrane via the HA-receptor CD44, 
further stabilizing the ECM.45 The stability of HA-aggrecan assemblies is pH 
dependent and is therefore thought to be involved in tissue responses to inflammation. 
This is also supported by the fact that HA binds an inflammation-response protein, 
TSG-6.46 Aggrecan can also build up supramolecular assemblies with collagen, the 
most abundant protein in the ECM.47 Both the protein core and the GAG chain on 
aggrecan participate in this interaction, which is likely dominated by electrostatics as 
there is a strong dependence on ionic strength and pH.48 
 
As the long and hydrophilic GAG chains also extend from the cell surfaces, they 
serve as cushions and lubricants around cells.49,50 This feature is especially important 
around chondrocytes in cartilage51 but can also function as a protective barrier around 
other cells, e.g. ovary cells.52 
3.2.2 Involvement	  in	  cancer	  progression	  
Patients suffering from cancer often have an increased risk for thrombosis, and for a 
long time, a common treatment has therefore been with anticoagulants such as heparin 
(section 3.1). As a positive side effect of this treatment, it has been shown in 
numerous studies that heparin also had an effect on the progression of the cancer itself. 
Multiple mechanisms describing this effect of heparin have been suggested; e.g., 
inhibition of metastasis by inhibiting cancer cell-induced thrombosis and an effect on 
angiogenesis and proliferation through the involvement in growth factor signaling 
(section 3.2.2). Considering the multiple effects of heparin and other GAGs, it is not 
surprising that studies investigating their effect in cancer suggest both inhibitory and 
stimulatory effects on cancer progression. Most studies involve full-length heparin, 
and low-molecular weight heparin might provide the needed response-control.17,53 
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3.2.3 Regulation	  of	  growth	  factor	  signaling	  
The presence of GAGs in the ECM as well as at the cell membrane is ideal for the 
involvement in extracellular and cell signaling events. Growth factors are small 
substances that convey signals between cells by binding to cell surface receptors, and 
thereby regulating cell proliferation and differentiation. Fibroblast growth factors 
(FGFs) are known to interact with HS-chains on proteoglycans in the cell membrane, 
which is likely a requirement for FGFs to bind to their receptor.14,54 
Bone morphogenetic protein 2 (BMP-2) is a member of the transforming growth 
factor β (TGF-β) superfamily that has been shown to induce bone formation in vivo 
and to promote cell differentiation towards the osteoblast linage in vitro.55,56 It is 
therefore a promising candidate to be used in research and in clinic to ameliorate bone 
formation. However, in vivo administration of growth factors suffers from short 
lifetimes due to rapid degradation in the ECM. Therefor different combinations of 
growth factors with a stabilizing agent are sought. Combining growth factors and 
GAGs has been shown to increase the lifetime of growth factors14,54, and to e.g. 
improve the effect of BMP-2 in vivo 57. 
3.2.4 Components	  in	  cell	  scaffolds	   	  
The structural properties of GAGs make them suitable to use in the engineering of 
scaffold used for directed cell growth in vitro and in vivo.58 CS and collagen is 
frequently combined to form scaffolds, and has e.g. been shown to support the 
adhesion of stem cell and differentiation towards the osteoblast lineage.59 
Functionalized and/or cross-linked HA is also often used as scaffold materials in both 
research and in clinic. For example, the commercially available HYAFF® consists of 
HA were the carboxyl groups are esterified by the addition of hydroxyl groups (e.g. 
benzyl alcohol), which gives HA increased hydrophobicity, increased attachment to 
cells, and slower degradation.60 For example, cartilage defects are treated by the use 
of a HYAFF® scaffold seeded with patient-own chondrocytes.61 Also less invasive 
techniques are being developed for bone and cartilage application, e.g. by injecting 
functionalized HA and a polymer showing a complementary chemistry, e.g. thiol-
acrylate.62 Surface coatings are often used to improve the ingrowth of biomaterials 
into tissues in vivo. Adsorbing multiple layers of polyelectrolytes, e.g. GAGs, is a 
straightforward way to coat biomaterials of various sizes and geometries (section 
4.2.4), and can be used to tune the response from surrounding cells.63 
 
Due to the positive effects of combining GAGs with growth factors, discussed in 
section 3.2.2, the addition of growth factors to the scaffolds mentioned above can be 
beneficial in many tissue-engineering applications. For example, multilayered 
polyelectrolyte structures have been loaded with BMP-264,65 and FGF-266 and used for 
cell growth in vitro. A significant release may not be necessary for activity of the 
growth factor, e.g. BMP-2 loaded in a HA scaffold was proposed to work in concert 
with the GAG while still in the structure.67 Also the HA-based scaffolds mentioned 
above are often combined with growth factors.61,68 
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3.3 Attachment	  factors	  for	  microbial	  pathogens	  
Infectious diseases occur when pathogenic microorganisms spread in the body. The 
ability for a microbe to localize in the body is often mediated by interactions with, and 
often by entry into cells. Viruses are small (∼102 nm) pathogens that enter cells in 
order to hijack the replication machinery, as they lack one of their own. The infection 
of a cell by a virus can be divided into six major steps that are common for all virus 
types: attachment, penetration, uncoating, replication, assembly and release. When 
the new virus particles, virions, are released, they can infect other cells nearby. Many 
viruses, e.g. herpes simplex virus (HSV),69,70 respiratory syncytial virus (RSV),69,71 
Ebola virus,72 and HIV,73 utilize cell surface GAGs as attachments factors (Figure 3). 
The herpes simplex virus type 1 (HSV-1) has been extensively studied in this aspect, 
where glycoprotein C in the viral envelope has been identified as binding to cell 
surface HS and CS.74,75 The GAG-binding region on the glycoproteins is thought to 
consist of clusters of positively charged amino acid residues that can bind to sulfated 
GAGs.75-78 
 
 
Figure 3. Simplified illustration of a herpes simplex virus entering a host cell via attachment 
and membrane fusion between the viral lipid envelope and the host cell membrane.  
Also certain bacteria (Helicobacter pylori, Bordetella pertussis, Chlamydia 
trachomatis) and other parasites (Plasmodium and Leishmania) have been shown to 
present GAG-binding proteins on their surfaces that are likely to be important in how 
they interact with host organisms.79 
 
The fact that GAGs act as attachment factors for different microbes opens up for the 
possibility of using GAGs as antimicrobial agents, where binding could potentially 
prevent attachment of the microbe and further effects on the host cell. This approach 
could in some case be better than the reverse, i.e. to block receptors on the host cell, 
since these receptors might also serve other important purposes for the cell.80 There 
are many in vitro studies suggesting an inhibitory effect on different microbes by the 
glycoproteins
HSV virion
envelope
capsid
GAGs
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addition of GAGs: e.g., HS/heparin can inhibit the attachment of the herpes simplex 
virus, respiratory syncytial virus and Japanese encephalitis virus to cells.69,81,82 HS has 
also been shown to inhibit attachment of HIV to cells by binding to the enveloped 
viral glycoprotein gp120.83 Plasmodium falciparum, the parasite causing the most 
dangerous type of malaria, has a very complex infectious cycle involving both 
mosquitos and humans. In one step, human erythrocytes infected with the parasite 
binds to the surface of endothelial cells, a step that can be inhibited by the addition of 
CS-A.84 
 
The antimicrobial activity of GAGs usually increases with the molecular weight, but 
the large size and high charge of the GAGs can limit their ability to penetrate tissue.85 
To ensure better reproducibility and to limit side-effects, short, synthetic versions of 
GAGs are attractive to use.86,87 A limiting aspect of using GAGs as antimicrobial 
agent is that a continuous administration is likely needed, as GAGs are known to 
inhibit binding of, but not to destroy, microbes. 
 
One should note that there are many other polysaccharides apart from GAGs (and 
therefore not discussed in this thesis) present on microbes that could potentially be 
used in the discovery of new antimicrobial drugs.36 
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4	  
Designing	  glycosaminoglycan-­‐presenting	  
surfaces	  
In this chapter, general aspects of biomolecular immobilization are discussed and 
exemplified by strategies and techniques of relevance for this thesis project, i.e. with a 
focus on biosensing. Examples from the literature where the different strategies have 
been used for immobilizing GAGs are also given.  
 
Immobilization of biomolecules to surfaces is a mean to control biomaterial properties, 
and also opens up for interaction studies using surface-based analytical techniques. 
Often, these techniques offer advantages over solution-based techniques, such as 
reduction of sample volumes. However, immobilization of one of the interaction 
partners is a requirement, which can be a limiting as well as a compromising factor. 
Care has to be taken to ensure that the immobilized molecule is still active, and to 
minimize non-specific interactions with the surface background. 
 
In the literature, there are many examples of immobilization of short glycans for the 
purpose of interactions studies. Especially glycan arrays, where different mono-, di-, 
and short oligosaccharides are immobilized to a surface, have been extensively used 
to probe interactions in a high throughput manner, and to study the influence of 
defined saccharide structures.88,89 Various immobilization strategies have been used 
for this, usually via the reducing end of the short saccharides.90 Immobilization of 
full-length GAGs is generally less common. However, the literature that is referred to 
in this chapter exemplifies immobilization of oligomeric and polymeric GAG 
derivatives. In this thesis, the ligand refers to the immobilized molecule, and the 
analyte to the molecule added in solution. 
4.1 Inert	  backgrounds	  
In order to obtain a desired function when immobilizing a biomolecule to a surface, it 
is often important to ensure an inert background. Two examples of such background 
surfaces are supported lipid bilayers (phospholipid membranes) and 
oligo(ethylene glycol)-modified surfaces. 
4.1.1 Supported	  Lipid	  Bilayers	  
A supported lipid bilayer (SLB) is a simple model mimicking the lipid membrane 
component of a cell membrane, relying on the self-assembly of lipid molecules.91 
Lipids have a hydrophilic head and a hydrophobic tail (Figure 4a), allowing them to 
form ordered structures when dissolved in certain solvents. In water, lipids can 
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arrange into vesicles, i.e., spherical bilayer structures with the heads directed to the 
water inside and outside the vesicle and the tails directed into the bilayer (Figure 4b). 
 
Figure 4. a) Schematic and chemical structure of a lipid, here 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphocholine (POPC). b) Lipids self-assemble into vesicles in a water solution. 
Commonly used methods for the formation of SLBs on solid surfaces include vesicle 
rupture (Figure 5)92 and also the Langmuir-Blodgett technique93. Vesicle rupture 
during physiological conditions is commonly seen on hydrophilic surfaces like silica94 
and mica95 but not on gold94 and titania94-96. These limitations can be overcome by 
optimizing the conditions during the bilayer formation, after which the physiological 
conditions are restored. For example, pH,96 ionic strength,97 or the presence of 
divalent cations92 can be tuned to enhance the interaction between the vesicles and the 
surface. Lipids in a self-assembled structure are often mobile, and cell membranes and 
lipid vesicles therefore normally show a certain degree of fluidity. This characteristic 
can, in the absence of a strong interaction between the lipid head group and the 
surface, be kept also in a SLB (see section 6.3).98 SLBs combined with surface-based 
techniques are extensively used as model systems to study processes taking place at or 
near a cell membrane. Due to the lateral mobility of the lipids, and the fact that certain 
SLBs are good in minimizing non-specific interactions, they are often modified to 
extend their usability in interaction studies.99-101  
 
In Paper I, functionalized SLBs were used for covalent immobilization of CS via two 
different strategies.  
 
 
Figure 5. Formation of a SLB on a silica surface. Vesicles adsorb and, when a critical 
coverage of is reached, rupture. Lipids functionalized with various chemical groups (x) can be 
incorporated in the vesicles and be a target for immobilization. 
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4.1.2 Self-­‐Assembled	  Monolayers	  
A self-assembled monolayer (SAM) refers to a single layer of molecules on a solid 
support formed from a spontaneous assembly.102 With the objective of forming close-
packed, oriented monolayer structures, alkanethiols adsorbing on a gold surface have 
been extensively studied (Figure 6). The semi-covalent bond between gold and sulfur 
in the thiol creates a strong link to the surface, and the non-thiolated end of the alkane 
chain can be functionalized with a chemically active group in order to bind other 
biomolecules.103 It is preferred that binding only occurs to these functional groups, 
and the use of poly(ethylene) glycol (PEG) or oligo(ethylene) glycol (OEG) chains as 
a part of the alkanes have been found to minimize unspecific binding of proteins,104 
also in combination with various functional groups e.g., carboxyl,104 and biotin 
groups105. 
 
Figure 6. Formation of a self-assembled monolayer. A gold surface is incubated in a solution 
containing thiol molecules for >12h. The high degree of orientation of the thiols allows for 
immobilization to a functional group (x) on the other end of the thiol molecule. 
SAMs functionalized with biotin was used in Paper II, III & IV for immobilization 
of various biotinylated GAG-derivatives.  
4.2 Immobilizing	  biomolecules	  
In order to obtain a stable surface modification, it is important to form a strong bond 
between the biomolecule of choice and the model surface. The orientation of the 
immobilized molecules, as well as the density of immobilized molecules on the 
surface is also important. 
4.2.1 Introducing	  functional	  groups	  
Biomolecules commonly contain various functional groups that can react with a 
suitable chemical group on a surface. Carboxyl, hydroxyl, and amine groups are 
typical examples of such functional groups. To extend the number of possible 
immobilization strategies, the biomolecule to be immobilized can be functionalized 
with foreign chemical groups. As GAGs are long, linear molecules, immobilization 
can either be made to multiple groups along the chain, resulting in a side-on 
immobilization, or to a single group at the end of the chain, resulting in an end-on 
immobilization of the GAG. This is independent on whether the GAG is 
functionalized or not (Figure 7). 
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Figure 7. Surface immobilization of GAGs can be made using either non-functionalized (a, c) 
or functionalized GAGs (b, d). Immobilization via multiple groups along the GAG chain results 
in a side-on configuration (a, b). If immobilization is made via a single functionality at the end 
of the GAG chain, an end-on configuration is obtained (a, b).  
4.2.2 Covalent	  coupling	  
Covalent coupling provides a strong bond between the biomolecule and the surface. 
When used in biosensing, it often enables regeneration of the sensor surface, which 
saves both time and material. The reaction between carboxyl groups and primary 
amines, forming amide bonds, is commonly employed for covalent immobilization of 
biomolecules.106 In the in vivo synthesis of proteins, the amide bond formation 
between the amino acids is a reaction catalyzed by the action of many enzymes and 
other molecules. In vitro, the use of coupling reagents is necessary for the reaction to 
take place. For example, the carboxyl group can be converted to a so called active 
ester by the use of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
(EDC). However, the EDC-ester is easily hydrolyzed in water, which is why the 
addition of N-hydroxysuccinimide (NHS) is common. NHS creates a more stable 
ester that efficiently reacts with the amine group (or other nucleophilic groups) of the 
ligand in water and at physiological pH (Figure 8).106,107 As a last step, ethanolamine 
is usually used to deactivate remaining carboxyl groups. 
 
 
Figure 8. A surface-bound carboxyl group reacts with a primary amine on a ligand and forms 
an amide bond. EDC and NHS are used as coupling reagents. 
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The above mentioned strategy has e.g. been used to immobilize GAGs to chitosan-
coated surfaces by coupling the carboxyl groups of the GAGs to primary amines in 
chitosan.108 The surfaces were designed to support mesenchymal stem cell growth. 
Other covalent strategies that have been used for the immobilization of GAGs include 
e.g., direct coupling of GAGs via the reducing end to a hydrazide-109 or primary 
amine-110 presenting surface. There are also examples of functionalized GAGs being 
used. For example, carboxyl groups along the chain of high molecular weight GAGs, 
and the reducing end of a low molecular weight GAGs, were functionalized with 
hydrazide groups to allow for immobilization to polydopamine-coated microtiter 
plates.111 The carboxyl groups of various GAGs have been functionalized with thiols, 
for the coupling to vinyl-terminated SAMs (section 4.1.2).112 Photo-coupling of HA to 
silicon rubber by the use of 4-benzoylbenzoic acid, has also been reported.113  
 
In this work, a covalent approach was used in Paper I, where CS was immobilized to 
two different SLBs.  
4.2.3 Biotin-­‐avidin	  binding	  	  
The strong interaction (KD ≈ 10-15 M) between biotin and avidin has been used to 
immobilize biomolecules to surfaces for decades.114 Bacterially derived streptavidin 
(SA) can be used instead of avidin, also exhibiting a strong binding to biotin 
(KD ≈ 10-13 M) (Figure 9). SA is non-glycosylated and has a pI closer to neutral pH 
(pI ≈ 5-6) and therefore shows lower non-specific interactions.115 Also neutravidin 
(pI = 6.3), a de-glycosylated variant of avidin, is sometimes used.116 All of the three 
variants have four binding sites for biotin. The biotin-avidin interaction is compatible 
with a range of conditions in terms of pH and temperature and has been used for a 
number of different systems, such as studies of DNA hybridization,100 and interaction 
studies involving proteins117 and polymers118 to mention some. 
 
 
Figure 9. a) The chemical structure of biotin. b) Schematic illustration of a biomolecule 
immobilized using the interaction between biotin (red) and streptavidin (grey) on a self-
assembled monolayer. 
For the immobilization of GAGs using this strategy, commercial sensor chips used for 
SPR-based sensing, consisting of a dextran matrix functionalized with SA, are often 
used. To enable immobilization, the amine groups along GAG chains are then 
functionalized with biotin groups.119,120 Due to possible interference of unreacted 
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biotin groups along the chain with subsequent interactions, it can be beneficial to 
functionalize the reducing end of the GAG instead.121 For example, end-on 
biotinylated HA has been immobilized to both SLBs (section 4.1.1)118 and SAMs 
(section 4.1.2)122. 
 
The interaction between biotin and SA was utilized in Paper II, III & IV for 
immobilization of biotinylated GAGs to SA-presenting SAMs. 
4.2.4 Molecular	  adsorption	  and	  the	  layer-­‐by-­‐layer	  technique	  
Perhaps the easiest way to immobilize GAGs on surfaces is by the use of mere 
adsorption. For example, sulfated polysaccharides have been immobilized by solvent 
evaporation to wells used in enzyme-linked immunosorbent assay (ELISA).123 
Electrostatic interaction between the negatively charge GAG chains and a positively 
charged surface is commonly employed, e.g., heparin has been immobilized to glass 
surfaces carrying positive charges due to a coating of poly-L-lysine.124 
 
By using a sufficiently high concentration of the immobilized GAG (or other charged 
polymers), the resulting surface charge upon adsorption is reversed, allowing for 
continued immobilization of oppositely charged polymers. The build-up of larger 
structures by alternately immobilizing polyionic and polycationic molecules 
(polyelectrolytes) with buffer washes in between, usually referred to as layer-by-layer 
assemblies, has been extensively used since the 90s (Figure 10).125 It requires no 
special equipment and is compatible also with non-flat substrates, which often makes 
it a suitable approach for coating various biomaterials. The properties of the resulting 
assembly are defined by used polyelectrolytes (molecular weight, charge, stiffness), 
together with the pH and ionic strength of the solvent.126-128 The growth of these films 
can be either linear or exponential, as a function of the number of layers. During 
exponential growth, a new deposition is proportional to the total film thickness, and 
occurs when one of the components diffuse in and out the film as the solvent is 
changed.129,130 The high charge and high molecular weight make GAGs suitable for 
the LbL strategy and numerous examples can be found; e.g., HA and poly-L-lysine129, 
CS and collagen131 and heparin and chitosan132. A common application of these layers 
is to use them as cell-substrates, with or without the incorporation of various active 
biomolecules, e.g., growth factors (section 3.2.1).67,132,133 
Layer-by-layer assemblies of heparin and chitosan were studied in Paper V. 
 
 
Figure 10. Formation of a polyelectrolyte multilayer via layer-by-layer assembly. 
Adapted from Decher et al. 1997.134 
 
1) polycation
2) wash
1) polyanion
2) wash
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5	  
Studying	  glycosaminoglycan	  interactions	  
This chapter highlights some important aspects to consider when studying GAG-
related interactions, complementing the ones listed in the previous chapter regarding 
a suitable immobilization of GAG to the surface, ensuring a retained biofunctionality. 
5.1 Specificity	  	  
The resemblance in molecular structure between different GAG types, and the varying 
molecular structure within one GAG type (Table 1), raise the question of specificity 
in GAG-related interactions.2,3,135 If a biomolecular interaction is specific, a 
biomolecule X reacts with, and only with, biomolecule A. For a non-specific 
interaction, where X can bind A, B, C, … a difference in selectivity (i.e. preference of 
binding) is seen. The thermodynamics of a system during an interaction is given by 
the Gibbs free energy: 
 ∆𝐺 = ∆𝐻 − 𝑇∆𝑆 Eq.	  1	  
 
where ΔH is the change in enthalpy (the internal energy), ΔS is the change in entropy 
(the disorder), and T is the temperature of the system. An interaction occurs 
spontaneously if ΔG	  <	  0. Often for non-specific, spontaneous interactions, the primary 
contribution to the decrease in ΔG comes from an increase in entropy of the 
system.136,137 For example, two hydrophobic entities in a water solvent are attracted to 
each other due to the increased disorder (ΔS) of water molecules upon binding. In the 
non-bound state, water molecules arrange around the hydrophobic entity, which is 
entropically unfavorable. Specificity in an interaction usually involves specific parts 
of the molecules, binding to one another in a directional manner. For example, a 
hydrogen atom bound to an electronegative atom (O, N) is attracted by other 
electronegative atoms (O, N or F) at short ranges. For such interactions, changes in 
enthalpy are usually significant. For GAG-protein interactions, hydrogen bonding can 
occur between the amino acids tyrosine, asparagine and glutamine and hydroxyl 
groups on the GAG.3 
 
However, non-directional interactions can still render specificity in a correct 3D-
arrangement of the two interacting partners. For example, the arrangements of 
positively charged, basic amino acids (lysine, arginine, histidine) have since long been 
suggested to be important in GAG-protein interactions, where a specific spacing 
between the amino acid side chains constitutes a GAG-binding region when the 
protein is correctly folded. The binding site on the protein surface should coincide 
with an appropriate charge distribution of the GAG chain, likely governed by the 
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sulfation pattern. This is often exemplified by the binding of heparin to 
antithrombin III (section 3.1).35,138 A similar reasoning could be applied for 
hydrophobic amino acids (leucine and tyrosine) interacting with the N-acetyl group of 
the GAG.3 
 
GAGs also posses secondary structures, as they adopt a helical structure in solution, 
stabilized by hydrogen bonds.139,140 Also, the occurrence of kinks in the helix 
structure as well as tertiary structures where multiple GAG chains align in β-sheets, 
has been suggested to be important to render specificity in interactions.141,142 
5.2 Multivalency	  	  
The affinity between a glycan structure and the glycan-binding site of a protein is 
generally low (KD ≈ 10-3 M).  In nature, high affinity interactions involving glycans is 
usually conveyed through multivalency, i.e. multiple recognition sites between two 
entities, e.g. when a virus binds to a cell or in cell-cell communication (Figure 
11a).143-145 Apart from giving rise to high affinity interactions, multivalent 
interactions in vivo are likely to allow control of interactions by other means, e.g. the 
spatial arrangement of receptors in a cell membrane. 
 
Multivalency also has important implications when studying interactions using 
surface-based analytical techniques (Figure 11b). If the analyte has multiple binding 
epitopes, the response will be highly dependent on the ligand density on the surface 
and quantitative evaluation is difficult. In such cases, immobilization of the analyte is 
preferred.  
 
 
Figure 11. Schematic illustration of multivalency a) in vivo, exemplified by cell-cell 
communication, b) in surface-based sensing. In i) and ii), the binding of a multivalent analyte 
is measured, and binding is dependent on the ligand density on the surface. In iii), the same 
interaction is studied inversely, making the studied interaction monovalent.  
5.3 Quantifying	  binding	  characteristics	  
For quantitative analysis of an interaction, binding constants are usually established. 
A simple biomolecular interaction can be represented by Eq.	  2. 
a) b) i)
ii)
iii)
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 𝐴 + 𝐵    𝑘!⇌𝑘!  𝐴𝐵   Eq.	  2	  
 
where A and B are two interacting molecules and ka and kd are the association and 
dissociation rate constants, respectively. The equilibrium association and dissociation 
constant can be defined as: 
 𝐾! = 𝐴𝐵𝐴 𝐵 ,      𝐾! = 1𝐾! = 𝐴 𝐵𝐴𝐵        Eq.	  3	  
 
Having the unit M,	   KD is more often used when quantitatively describing an 
interaction, where a low value indicates an interaction of high affinity. If the 
interaction is studied using surface-based techniques, the binding of analyte A to 
ligand B can be related to the Langmuir adsorption isotherm, and the rate of change in 
surface coverage can then be described by: 
 𝑑𝜃𝑑𝑡 = 𝑘! 𝐴 𝜃!"# − 𝜃 − 𝑘!𝜃         Eq.	  4	  
 
where the first part represents association and the second part dissociation. θ is the 
surface coverage at time t	  and	  θmax is the maximum surface coverage. At equilibrium, 
the rate of change, dθ/dt is zero, and solving for θ then gives: 
 𝜃 = 𝐴 𝜃!"#𝐾! + 𝐴                Eq.	  5	  
 
where KD	  =	  kd/ka. Putting [A] = KD	  gives θ	  =	  θmax/2, in other words, KD equals the 
analyte bulk concentration at which half of the ligands on the surface are occupied. 
Also, by fitting the dissociation curve in order to get kd, and by fitting the integral of 
Eq.	  4 to the association curve, KD	  can be calculated by	  kd/ka. 
 
Fitting measurement data to Eq.	   5 in order to get KD is only reasonable if the 
Langmuir model holds, i.e. pure sample, homogenous surface with all sites equal and 
a non-cooperative binding. The presence of cooperativity in the interaction can be 
accounted for by extending Eq.	  5, e.g., by: 146,147 
 𝜃 = [𝐴]!𝜃!"#𝐾!.!! + [𝐴]!   Eq.	  6	  
 
where n > 1 indicates positive cooperativity. For n = 1, Eq.	  6 = Eq.	  5 and K0.5	  =	  KD.  
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6	  
Experimental	  techniques	  
6.1 Quartz	  Crystal	  Microbalance	  with	  Dissipation	  Monitoring	  
Quartz crystal microbalance with dissipation monitoring (QCM-D) is a mass-sensitive 
technique based on the oscillation of a quartz crystal. Quartz is a piezoelectric 
material, i.e., an electrical potential is developed when the material is subjected to 
mechanical stress. Conversely, a deformation of the crystal can be brought about if a 
potential is applied across the material. The mode of deformation is dependent on how 
the potential is applied relative to the crystal structure. In QCM techniques, an 
alternating potential is typically applied to a thin AT-cut single-crystalline disc with 
one gold electrode on each side, resulting in an oscillatory motion in the so-called 
shear-thickness mode (Figure 12).148,149 
 
Figure 12. When an alternating potential is applied to an AT-cut quartz disc, it oscillates in a 
shear-thickness mode. 
The most stable oscillation occurs at the resonance frequencies of the crystal, where a 
substantial part of the added energy is converted into motion. The fundamental 
resonance frequency can be described by: 
 𝑓! = 𝜇!𝜌!2𝑚!  Eq.	  7	  
 
where mc is the mass of the crystal, ρc is the density of the crystal, and µc is the shear 
elastic modulus of the crystal.150 For common QCM crystal sensors f0 = 5 MHz. If the 
frequency of the driving voltage matches the fundamental frequency of the crystal (or 
odd multiples of it), a standing wave is created in the crystal.148 Adsorption of a 
biomolecule to the sensor surface typically leads to a decrease in the resonance 
frequency, since it is inversely proportional to the mass of the crystal sensor (Eq.	  7, 
Figure 13). The sensing depth of the QCM technique is dependent on the extension of 
the shear oscillation into the solution, which in water is ~250 nm but increases with 
increased rigidity of the probed material.151 As the measurement is based on 
mechanical oscillations, all mass that is acoustically coupled to the motion of the 
crystal sensor will be measured, i.e., including the solvent associated with the 
adsorbed molecules. Hence, the detected mass is the sum of the mass of the adsorbed 
layer and the mass of the associated solvent: 
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𝑚 = 𝑚!"#$% +𝑚!"#$%&'   Eq.	  8	  
 
By combining QCM with another technique that measures only mlayer, e.g., surface 
plasmon resonance-based techniques (SPR, section 6.2), the extent of hydration of the 
adsorbed layer can be estimated under the assumption that the modeled thicknesses, 
as well as other factors during the two experiments, are similar.100,152 
 
Apart from measuring the change in frequency upon adsorption, the damping, or 
dissipation, is also measured by monitoring the time it takes for the oscillation to 
decay, τ, as the driving potential is switched off. During a measurement, the driving 
potential is continuously switched on and off, allowing a continuous measurement of 
the dissipation factor. The dissipation can be related to the energy stored and lost 
(dissipated) by153 
 𝐷 = 12𝜋 ∙ 𝐸!"##"$%&'!𝐸!"#$%& = 1𝜋𝑓𝜏 Eq.	  9	  
 
where f is the resonance frequency and Estored and Edissipated, the stored and dissipated 
energy, respectively, during one oscillation period. For rigid films, the oscillation 
decays quickly and the dissipation is low. For soft, viscoelastic film, the dissipation is 
higher (Figure 13). 
 
Figure 13. Illustrative QCM-D frequency and dissipation shifts describing adsorption of 
material. As material adsorbs, the resonance frequency (black) decreases and dissipation 
(light grey) increases. If the adsorbed layer is soft the dissipation response is large (solid), if it 
is dense, the dissipation response is small (dashed). 
6.1.1 Modeling	  of	  QCM-­‐D	  data	  
The simplest and most commonly used conversion of QCM-D frequency shifts to 
adsorbed mass is the Sauerbrey relation, which is derived from the resonance 
frequency of the quartz crystal sensor, Eq.	  7:  
 ∆𝑚 = −𝐶∆𝑓!𝑛        	  Eq.	  10	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were Δm is the change in mass, C is a crystal specific constant (17.7 ng/(cm2⋅Hz)), n 
is the harmonic number and Δfn	   the frequency change measured for that 
harmonic.150,154 As seen from 	  Eq.	  10, the dissipation is not taken into account. The 
Sauerbrey equation hence only holds for thin, rigid layers displaying small dissipation 
shifts. As a rule of thumb, the Sauerbrey equation can be used if153 
 ∆𝐷!∆𝑓! 𝑛 ≪ 0.4 ∙ 10!!𝐻𝑧!!               Eq.	  11	  
 
This is often realized from that the frequency signal for the different harmonics 
overlap. Apart from this, the adsorbed layer should be tightly coupled to the sensor, 
evenly distributed, and mlayer	  <<	  mc. 
 
When Eq.	   11, or other requirements for the Sauerbrey equation do not hold, the 
Sauerbrey equation will give an underestimation of the mass, as the propagation of the 
standing wave then depends on the viscoelastic properties of the layer and the bulk 
liquid. A more elaborate physical model is then needed.155,156 The dynamic shear 
modulus for a viscoelastic material can be described as 
 𝐺 = 𝐺! + 𝑖𝐺!!                     	  Eq.	  12	  
 𝐺! = 𝜇, 𝐺!! = 𝜔𝜂               Eq.	  13	  
 
where ω is the angular frequency of the oscillation, µ the shear elastic modulus and η 
the shear viscosity. G’ represents the elastic contribution and describes the energy 
stored, G’’ represents the viscous contribution and describes the energy losses in the 
system. 
 
Eq.	  12 and Eq.	  13 are used to define the equation for the shear wave propagating in a 
viscoelastic medium. In terms of QCM-D experiments, some boundary conditions 
apply, e.g., the no-slip condition meaning that the adlayer on top of the sensor must be 
firmly attached and not slide during the oscillation. With the boundary conditions, the 
solution of the wave equation can be solved into expressions for Δf and ΔD depending 
on properties of the crystal sensor, the viscoelasticity of the adlayer and the 
viscoelastic contribution from the surrounding bulk liquid (Figure 14).156 Δf also 
depends on the mass of the adlayers. In essence, the effect of measuring in a liquid 
environment emphasizes the viscoelastic properties of the adlayer, hence making it 
possible to measure them.155 
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Figure 14. Shear elastic modulus µ, shear viscosity η, height h, mass m, and density ρ for a 
QCM-D crystal sensor c, carrying a viscoelastic adlayer a, in bulk liquid l.  
In practice, when solving the wave equation for a particular experiment, properties of 
the crystal sensor and the liquid have to be known, and the density of the adlayer 
needs to be estimated. For a biological, soft layer, ρa = 1 g/cm3 is often used. Even 
then, the equation leaves several unknown parameters, which can be solved by 
including data from several harmonics. 
6.2 Surface	  Plasmon	  Resonance	  
Surface plasmon resonance, SPR, refers to an optical technique that aids detection of 
mass adsorption at a surface interface based on changes in the interfacial refractive 
index. A surface plasmon is a charge-density wave that can exist at the interface 
between two media where the dielectric constants are of opposite sign, e.g., between a 
free-electron metal (e.g. gold or silver) and a dielectric.157,158 The surface plasmon can 
be excited by light that fulfills momentum matching, i.e., resonance conditions 
between the surface plasmon and the incoming light. The excitation conditions for 
surface plasmona are highly sensitive to changes at the interface where it propagates. 
When material with optical properties different from the bulk adsorbs to the metal 
surface, the resonance condition for the plasmon is changed.  
 
To measure this phenomenon, a typical SPR instrument is usually built according to 
the Kretschmann configuration (Figure 15).159 A glass prism is coated with a thin 
metal film, usually gold.157 Plane-polarized light is applied through the prism such 
that it hits the interface at an angle larger than the critical angle, θ > θc, where total 
internal reflection occurs. Under these conditions, no light is transmitted through the 
gold film but an electrical field wave (the evanescent field) is created, having an 
intensity that decays exponentially from the surface into the ambient medium. 
 
mc , μc
ηa , ρa , ha , μa 
ηl , ρl , hl
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Figure 15. The Kretschmann configuration of an SPR instrument. kx and ksp are the wave 
vectors for the horizontal component of the light and the plasmon and εa,	  εm and εg are the 
dielectric constants for the ambient medium, the metal and the glass prism. 
The wave vectors for the plasmon, ksp, and for the parallel component of the incident 
light, kx, are given by: 
 𝑘!" = 𝜔𝑐 𝜀!(𝜔)𝜀!𝜀! 𝜔 + 𝜀!   = 𝜀! ≫ 𝜀! = 𝜔𝑐 𝜀! = 𝜔𝑐   𝑛!               Eq.	  14	  
 𝑘! = 𝜔𝑐 𝜀!𝑠𝑖𝑛𝜃                   Eq.	  15	  
 
where ω is the angular frequency, c is the speed of light, εa,	  εm and εg are the dielectric 
constants for the ambient medium, the metal, and the glass prism, na is the refractive 
index of the ambient medium and θ is the incident angle of the light.158 Note that 
|εm| >> |εa|	  in Eq.	  14, which is required for the plasmon to exist.	  For the plasmon and 
the light to be in resonance, kx and ksp need to be equal. Energy is then transferred 
from the light to the plasmon, causing a dip in the intensity of the reflected light 
sensed by a detector.158,160 As molecules attach to the sensor surface, Eq.	   14 will 
change due to changes in the refractive index, na. In order for ksp = kx to hold, the 
angle of incidence, θ, has to change. By scanning the incident angle until the 
resonance condition is found, the new refractive index,	  na, can be calculated.157 
 
When communicating SPR data, the displacement of the resonance angle is 
sometimes reported. For the commonly used BIAcore instrument, values are often 
given in resonance units (RU). The RU values depend on the change in refractive 
index, Δn, which in turn is related to the surface concentration of the adsorbed 
biomolecule.161 The change in mass, or surface coverage ng/cm2, can be estimated 
using Eq.	  16.100 
 
θ
evanescent field
ksp
light
kx
glass prism
metal film
εg
εm
εa
detector
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∆𝑚 = 𝐶!"#∆𝑅𝑈𝛽                  Eq.	  16	  
 
where CSPR is a constant accounting for the decay length of the evanescent field, the 
sensitivity of the instrument and the refractive index increment for the adsorbed 
substance, dn/dC. β is a factor compensating for the distance from the sensing surface.  
 
As opposed to the QCM-D technique (section 6.1), solvent associated with the 
adsorbed molecules is not measured, since it is only entities with a refractive index 
that is different from the surrounding solvent that is sensed. Measurements with SPR 
are often used to estimate affinity and kinetics for a given biomolecular interaction 
(section 5.3). 
6.3 Fluorescence	  Recovery	  After	  Photobleaching	  
Fluorescence recovery after photobleaching (FRAP), is a microscopy method used to 
monitor the lateral diffusivity of fluorescently labelled molecules.162 This can be 
useful for different kinds of systems, but a typical application is to monitor the 
mobility of lipids in a lipid bilayer (section 4.1.1). Apart from ensuring successful 
formation of a SLB, the technique can be used to probe changes in the fluidity due to 
an altered lipid composition or coupling of biomolecules to the lipid bilayer.163 A 
fraction of fluorescently labelled lipids is incorporated into the SLB, and a small spot 
in the SLB is bleached by a high intensity light pulse. If the bilayer is fluid, the 
bleached and non-bleached lipids will diffuse and mix, and the fluorescence in the 
bleached spot will recover. By analyzing the recovery, the diffusion constant can be 
calculated.164 
6.4 Isoelectric	  point	  analysis	  
The charge of a surface used in biomedical applications influence the immune 
complement system, blood coagulation and protein adsorption in general. It is 
therefore important in understanding the overall behavior of a material for the use in 
diagnostics, implants and as cell culture substrates. When a charged surface or particle 
is placed in an electrolyte, a charged double layer is formed close to the surface. The 
potential of this double layers, the zeta-potential or ζ-potential, can be used as an 
indicator of the surface charge.165 For surfaces, this is commonly measured as a 
streaming potential or streaming current, by letting the surface under study constitute 
the walls of a narrow channel (∼µm). When pushing an electrolyte through the 
channel, a fraction of the oppositely charged ions (opposite to the surface) is retained 
in the formed double layer. This violates the charge neutrality of the electrolyte and 
therefore a streaming current develops. The net stream of ions can be measured 
directly by electrodes on each end of the channel and the ζ-potential can be calculated 
by Eq.	  17.166 
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𝜁 = 𝑑𝐼𝑑𝑝 ∙ ηε! ∙ ε! ∙ LA                       Eq.	  17	  
 
where dI/dp is the slope of streaming current I versus the differential pressure across 
the sample p, η is the viscosity of the solution, ε0	  and εr is the vacuum permittivity 
and the relative permittivity for the electrolyte, L and A the length and cross-section 
area of the channel. The isoelectric point, i.e. the pH where the ζ-potential is zero, can 
be determined by measuring the ζ-potential during a pH titration. 
6.5 Contact	  angle	  goniometry	  
The wetting property of a surface, i.e. if the surface is hydrophilic or hydrophobic, 
along with the surface charge (section 6.4), is an important property in determining 
the response from biological materials.167 Wetting properties can be easily estimated 
by measuring the contact angle θ of a liquid, typically water, on the surface. The 
surface is considered hydrophilic if θ	   <	   90°,	   and	   hydrophobic	   if	  θ	   >	   90°	   (Figure 
16).168 The contact angle depends on the interfacial energy between the three phases 
present: solid s, liquid l, vapor v, according to the Young’s equation:169 
 𝛾!" = 𝛾!" + 𝛾!"𝑐𝑜𝑠𝜃                 Eq.	  18	  
 
 
Figure 16. Contact angles for surfaces with different wettability; a) a super-hydrophilic surface 
with θ<10°, b) a hydrophilic surface with θ<90°, c) a hydrophobic surface with θ>90°. 
The wetting properties of a surface depend on its surface energy. The surface energy 
can be considered as the energy needed to create a new surface from a bulk material, 
i.e. to break the chemical bonds in the bulk. To calculate the surface energy from the 
contact angle is not straight-forward and many models have been suggested.170 A 
common approach is to measure contact angles of liquids having different surface 
tensions γlv, and plotting cos(θ) versus γlv. The surface energy is then equal to the 
liquid surface tension γlv at cos(θ) = 1.171 
a) b) c)
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7	  
Results	  
7.1 Summary	  of	  appended	  papers	  
The aim of this thesis project was to study GAG-related interactions with various 
biological entities (proteins, cells, viruses) in a reliable way using surface sensitive 
analytical techniques. A first step towards this is surface immobilization of GAGs, 
why this has been a major part. In line with this, the biofunctionality of the 
immobilized GAGs was assessed using different proteins. Based on these results, one 
strategy was chosen and used for further interaction studies.  
 
In the first study, covalent immobilization of CS to SLBs was investigated via two 
strategies, either using naturally occurring carboxyl groups on CS, or using 
synthetically introduced hydrazide groups (Paper I). The results from this study 
emphasized the influence of introduced functional groups on the resulting 
biofunctionality of the immobilized GAGs. To investigate this further, and also how 
orientation of the GAGs influence protein interactions, HA and CS functionalized 
with biotin at the reducing end of the chain, as well as along the chain, were 
immobilized to a SA-presenting SAM (Paper II). A clear difference in the interaction 
with the GAG-degrading enzyme hyaluronidase was seen depending on the placement 
of biotin groups. The influence of the orientation of the immobilized GAG on the 
interaction between CS and the proteoglycan aggrecan was also studied. Based on 
these studies, end-on immobilization of GAGs using biotin-SA interactions was 
chosen as a suitable platform for further interaction studies. The platform was then 
used to study the interaction of gC, a glycoprotein isolation from HSV-1, with GAGs 
(Paper III). The results revealed important aspects regarding certain glycosylated 
structures on gC, by comparing binding between native gC and a mutant gC, lacking 
these glycosylated structures. The same platform was also used to study interactions 
with the growth factor BMP-2, as well as the initial binding of chondrocytes to 
hyaluronan (Paper IV), showing interesting effects from the cells on the underlying 
HA. In a separate study, the build-up of layer-by-layer structures consisting of heparin 
and chitosan was studied (Paper V). 
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7.2 Glycosaminoglycan	  library	  	  
The starting materials for the GAG derivatives used in this thesis work were obtained 
from commercial sources. In order to investigate different immobilization techniques, 
some GAGs were functionalized either via functional groups along the chain, or via 
the open form of the reducing end, presenting an aldehyde group (Figure 7, Figure 
17). Some GAG derivatives were also sulfated. Functionalization and sulfation were 
carried out by our collaborators, INNOVENT (Jena, Germany). A full list of the 
GAGs used in the appended papers can be found in Table 2. 
 
 
Figure 17. In the upper part of the figure, the molecular structure of a GAG (exemplified by 
CS) is shown, with the closed and the open structure of the reducing end. In the lower part of 
the figure, two strategies for the functionalization of CS by hydrazide reactions are 
exemplified: a) side-on functionalization via carboxyl groups along the GAG chain, and b) 
end-on functionalization to the aldehyde in the open structure of the reducing end. In Paper I, 
R=NH-NH2 (hydrazide), in Paper II, R=C4H8-biotin 
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Table 2: GAG derivatives used in the thesis work. 
 
Abbreviation Mw [kDa] Functionalization
3 DSsulfate3 In paper 
Chondroitin 
Sulfate1 
CS 20 - 0.9 I 
h-CS 0.05 20 DShydrazide<0.05 0.9 I 
h-CS 0.2 20 DShydrazide=0.2 0.9 I 
h-CS 0.4 20 DShydrazide=0.4 0.9 I 
b-CS 20 end-on biotin 0.9 II, III 
b-CS 0.5%2 20 DSbiotin=0.53%2 0.9 II 
sCS 20 - 3.44 II 
b-sCS 0.9%2 20 DSbiotin=0.88%2 3.44 II 
Hyaluronan HA 1000 - - II 
HA 15 - - - 
b-HA 23 end-on biotin - II, III, IV 
b-HA 2.6% 1000 DSbiotin=2.6%  - II 
 b-HA 4.3% 90 DSbiotin=4.3%  - II 
 b-sHA 30 end-on biotin 3.14 II, III 
Heparin HS 11 - 1 V 
Chitosan CHI 500 - - V 
1: 70% CS-A, 30% CS-C 
2: corrected values from those presented in Paper I 
3: DShydrazide: average number of hydrazide substituents per repeating unit, DSbiotin: 100% 
indicates one biotin per repeating unit, DSsulfate: average number of sulfate groups per 
repeating unit. 
4: synthetically introduced sulfation 
7.3 Strategies	  to	  immobilize	  glycosaminoglycans	  
7.3.1 Covalent	  immobilization	  to	  supported	  lipid	  bilayers	  (Paper	  I)	  
The immobilization of GAGs to SLBs (section 4.1.1) could be viewed as having two 
aims: i) developing strategies for more advanced cell membrane mimics by the 
addition of cell membrane GAGs, and ii) providing a good platform for GAG 
interaction studies when using surface-based analytical techniques as certain SLBs 
has proven to be good in minimizing non-specific interactions during biomolecular 
interaction studies.99,172 In Paper I, the GAG CS was covalently attached to SLBs via 
two different strategies: either by activating the naturally occurring carboxyl groups 
on CS and coupling them to amine groups on the surface (Figure 7a), or by coupling 
activated carboxyl groups on the surface to hydrazide molecules introduced on CS 
(according to Figure 7b and Figure 17a, here termed h-CS). Both strategies were 
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followed in QCM-D. Accordingly, two different types of SLB were formed: one 
carboxyl-functionalized (SLB-COOH), and one amino-functionalized (SLB-NH2) 
(Figure 18). Different ratios of the functionalized lipids were tried and SLB-COOH 
having a ratio of functional lipids up to 20% could be successfully formed. Formation 
of SLB-NH2 was limited by the possibility to prepare a homogenous lipid mixture as 
lipid vesicles aggregated at a mole fraction of functionalized lipids >60%. The bilayer 
formation processes depend on the interaction between the charged head groups and 
the surface; a higher ratio of negatively charged lipid head groups aggravate/delay 
bilayer formation whereas the opposite is true when the ratio of positive lipid head 
groups is increased.  
 
h-CS variants with different degrees of hydrazide functionalization were immobilized 
to SLB-COOH by activating the carboxyl groups on the surface by EDC/NHS 
reagents (section 4.2.2) (Figure 19a). Coupled amounts increased with increasing 
hydrazide functionalization and decreased with increasing ratio of functionalized head 
groups in the bilayer, likely due to a charged repulsion between the bilayer and the 
negatively charged CS chain. CS was also end-on functionalized with hydrazide but 
this did not lead to any detectable immobilized amounts on a SLB. As a second 
strategy, naturally occurring carboxyl groups on non-functionalized CS were activated 
in bulk, also by the use of EDC/NHS reagents, and coupled to SLB-NH2 bilayers 
(Figure 19b). Immobilized amounts increased with increasing ration of functional 
lipids in the bilayer.  
 
Both strategies resulted in thin layers of CS (25-55 ng/cm2), immobilized in a side-on 
configuration. The viscoelastic properties were similar for layers obtain by the two 
strategies, as seen by similar ΔD/Δf ratios. The dynamic structure of SLBs could pose 
problems when immobilizing long chains or large structures as lipid material could 
potentially be removed.118 Thus for comparison, h-CS was immobilized to SAM-
COOH. Only small differences were seen when comparing the immobilized amount 
of CS to the SAM, suggesting that the fraction of DOPE-COOH lipids is a rather 
good measure of the number of carboxyl groups exposed at the surface and that the 
low response is not caused by removal of lipid material. 
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Figure 18. QCM-D frequency and dissipation shifts for the formation of a) SLB-COOH and b) 
SLB-NH2 having different fractions of functionalized lipids. 
 
Figure 19. QCM-D frequency and dissipation shifts for the immobilizing of CS to SLBs. a) 
h-CS (DShydr. 0.2) added to activated (solid line) and non-activated (dashed line) SLB-
COOH 5%. b) stepwise addition of bulk activated CS to SLB-NH2 5% (dashed line) and to 
SLB-NH2 55% (solid line). 
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The lateral diffusion of lipids in the SLB was also assessed using fluorescence 
recovery after photobleaching (FRAP). The diffusion coefficient (D) of fluorescently 
labeled lipids was calculated, showing no significant difference between a functional 
bilayer and bilayer with immobilized CS. If the lipids in the bilayer have a retained 
fluidity, it is likely that the immobilized CS chain can adopt a relaxed configuration. 
ΔD/Δf ratios were in fact higher for h-CS immobilized on SLB-COOH compared to 
h-CS immobilized to a comparable SAM.  
 
 
Figure 20. FRAP images of SLB-NH2 20% containing 1% of fluorescently labeled lipid (NBD-
POPC) a) without and b) with immobilized CS. After bleaching, 30 images were taken with a 5 
s pause in between. The last image is shown to the right in each section. 
7.3.2 Immobilization	  via	  biotin-­‐streptavidin	  on	  self-­‐assembled	  
monolayers	  (Paper	  II-­‐IV)	  
The immobilization of various biotinylated GAGs were made to a SA-presenting 
SAM (section 4.1.2 & 4.2.3). The SAM has been previously developed and 
characterized for QCM-D measurements, and consists of a mixture of disulfide OEGs 
(99% dS-OEG-OH + 1% dS-OEG-biotin).105 The GAGs were primarily end-on 
biotinylated according to Figure 17b, but side-on biotinylation according Figure 17a, 
was also used. Immobilizations of end-on biotinylated chondroitin sulfate (b-CS), 
hyaluronan (b-HA) and sulfated hyaluronan (b-sHA) was monitored by QCM-D and 
SPR-based sensing (Figure 7d, Figure 21). Characteristics for the layers are 
summarized in Table 3. 
 
 
D = 0.87 ± 0.2 µm2/s D = 0.95 ± 0.1 µm2/s 
a) b)
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Figure 21. Immobilization of b-HA (dashed line), b-sHA (solid line) and b-CS (dotted line) to 
SA on a biotinylated OEG-SAM as monitored by a) QCM-D frequency and dissipation signals 
and b) SPR response. In order to reach saturation of b-CS multiple injections were needed 
(not shown). Arrows indicate rinsing. 
Table 3. Physical and optical properties, along with measured masses and estimated water 
content of end-on immobilized GAGs. 
 Mw [kDa] 
mQCM-Da 
[ng/cm2] 
mSPRb 
[ng/cm2] 
Chain-to-chain 
distance [nm]c 
hydration 
[%] 
b-HA 30 1080 20 ± 1 15 ± 3 98 
b-CS 20 110 11 ± 2 19 ± 6 90 
b-sHA 23 230 21 ± 2 17 ± 4 91 
a: obtained through viscoelastic modeling, section 6.1.1. 
b: calculated using Eq 16 and dn/dC from literature values173-176, see supporting information of 
Paper II 
c: assuming hexagonal close-packing 
 
The degree of hydration estimated from these measurements are in good agreement 
with previously published data on HA.118 The lower grafting density of b-CS could 
potentially be explained, despite careful purification by dialysis, by the presence of 
free biotin residues in the sample. 
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To further characterize the GAG layers, ζ-potential measurements and contact angle 
measurements were made (Figure 22). 
 
 
Figure 22. a) ζ-potential dependence on pH for SA (solid line), b-HA (dashed line), and b-sHA 
(dotted line). b) Water contact angles for surfaces displaying SA only, and SA with end-on 
immobilized GAGs. 
No great differences between the GAG layers were measured using these techniques. 
The GAGs differ between one another primarily in terms of sulfation. For ζ-potential, 
the presence of sulfate groups is expected to lower the isoelectric point (ζ-potential at 
pH = 0) due to a higher charge of the polymer. The influence of sulfate groups on the 
wettability is less straightforward as both hydroxyl groups and sulfate groups are 
expected to yield a very hydrophilic polymer. Surface immobilization of HMW HA in 
a side-on configuration has previously shown to yield lower contact angles compared 
to CS immobilized in the same way, although generally more hydrophobic than the 
values seen in Figure 22b.111 It is important to note that both the QCM-D and SPR 
results point to a difference in surface coverage between the GAG derivatives, leading 
to a different exposure of the underlying SA layer in each of the cases. There could 
therefore be an effect from the underlying SA layer, increasing the isoelectric point 
and the contact angle. Using longer GAG chains could reduce this effect and 
potentially show a greater difference between the derivatives. 
 
The strategy of immobilizing GAGs via biotin-SA can obviously be used together 
with other surface modifications than a SAM, e.g., by including a fraction of 
biotinylated lipids into a SLB. The thiol-SAM used here is compatible with gold 
surfaces, which enables comparative experiments using of both QCM-D and SPR. 
 	  
 ζ
 p
ot
en
tia
l [
m
V]
pH
60
40
20
0
-20
-40
-60
-80
-100
-120
35
30
25
20Co
nt
an
t a
ng
le
 [°
]
SA        b-HA       b-sHA      b-CS
           end-on     end-on    end-on
3           4          5           6           7 
a) b)
RESULTS 
 
 39 
7.3.3 Build-­‐up	  of	  layer-­‐by-­‐layer	  structures	  (Paper	  V)	  
In Paper V, characteristics of layer-by-layer structures (section 4.2.4) consisting of 
alternate layers of anionic heparin and cationic chitosan were investigated (Figure 7a). 
The chitosan solution was always applied at pH 4 but the pH of heparin was varied, as 
pH is known to affect the properties of a multilayer. This lead to three different 
assembly strategies (Figure 23); a) heparin applied at pH 4, b) heparin applied at pH 
9, c) heparin applied at pH 4 up to the 7th layer and at pH 9 for the remaining layers. 
Among other techniques, the layer build-up was studied using QCM-D. 
 
 
Figure 23. QCM-D frequency and dissipation signals for alternate additions of the anion 
heparin (blue) and the cation chitosan (black). 5th and 7th harmonic shown. Chitosan was 
applied at pH 4 at all times and heparin was applied at a) pH 4, b) pH 9 (dark blue), and c) pH 
4 during the first three layers and pH 9 for the last three layers. Heparin addition (including 
rinsing) is marked by blue shading in the graph, light blue = pH 4, dark blue = pH 9. 
The alteration in dissipation represents the change between swollen and condensed 
states of the multilayer; layers swell as chitosan is added, and condense as heparin is 
added. During strategy a) when heparin was applied at pH 4, ion paring is likely the 
dominating interaction between chitosan and heparin, as chitosan is positively 
charged at this pH. When heparin is applied at pH 9 according to strategy b), the 
underlying chitosan is non-protonated and ion pairing is hence not possible. The 
observed ∆f is also smaller. It is interesting to note that the shift from pH 4 to pH 9 for 
the heparin solution in strategy c), causes a layer degradation during the addition of 
chitosan. This has been seen before for multilayer systems consisting of oligomers, 
like heparin used here.177 Likely, the formation of soluble complexes is favored 
compared to adsorption to the surface. However not very apparent during strategy b), 
this is a likely mechanism for the limited layer growth seen. Also, the smaller heparin 
molecule is likely to diffuse in and out of the layer during build-up, especially at pH 9 
when ion pairing is not extensive. This contributes to the some-what exponential 
growth seen,129,130 and leads also to that the resulting structure does not consist of 
well-separated polymer sheets, but is a more intermingled structure. 
a) b) c)
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Additional experiments using the layer-by-layer structures showed that adsorption of 
fibronectin, as well as cell attachment and spreading, was low on layers built 
according to strategy a), but higher to the denser layers formed using strategy b). 
Strategy c) resulted in improved cell attachment compared to layers formed using 
strategy a). At the same time, these layers are thicker than layers former using 
strategy c), which could allow for the incorporation of growth factors. 
7.4 Biofunctionality	  of	  immobilized	  glycosaminoglycans	  
7.4.1 Influence	  of	  introduced	  functional	  groups	  (Paper	  I	  &	  II)	  
Many of the immobilizing strategies mentioned in section 4.2 include 
functionalization of the GAG with an active molecule of some sort. Introducing 
functional groups on the GAG could change its characteristics, and especially affect 
how it interacts with other biomolecules. This aspect was highlighted in Paper I 
and II. 
 
In Paper I, the interaction between CS immobilized as described in section 7.3.1 and 
the growth factor bone morphogenetic protein-2 (BMP-2) was studied with QCM-D 
(Figure 24). The interactions between GAGs and growth factors are interesting to 
study because of the potential of combining the two in therapeutic applications to 
obtain an increased lifetime and stability of the growth factor (section 3.2.1). BMP-2 
is frequently used in research, primarily with the aim of stimulating bone growth and 
regeneration.  
RESULTS 
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Figure 24. QCM-D frequency and dissipation signals when adding BMP-2 to a) h-CS 
immobilized to SLB-COOH 5% and b) CS immobilized to SLB-NH2 20% (solid lines) and to 
SLBs without immobilized CS (dashed lines). Addition was made in low (top) and high 
(bottom) ionic strength acetate buffer. After addition, the system was rinsed with the acetate 
buffer just used (indicated in the graph), and later with PBS (not shown). 
In low ionic strength buffer there is no difference between BMP-2 binding to CS or to 
the negatively charged SLB-COOH. Increasing the ionic strength displays a lower but 
presumably more specific interaction between h-CS and BMP-2. When using the 
positively charged SLB-NH2, there is no non-specific interaction (independent of the 
ionic strength) as the positively charged BMP-2 is rather repelled. Higher amounts of 
BMP-2 bound to CS immobilized on SLB-NH2 (Figure 24b) compared to h-CS 
immobilized on SLB-COOH (Figure 24a) at high ionic strength. This can in part be 
due to that the added mass of CS when using strategy b) is about double as compared 
to strategy a, but more importantly CS is here expected to be more in its native form, 
as it has not been functionalized with hydrazide. Structural rearrangements are likely 
to occur as BMP-2 interacts with CS, and the reaction did not reach equilibrium 
during the used conditions. The appearance could also be due to an aggregation of 
BMP-2 induced at the sensor surface, but this was not seen for BMP-2 interacting 
with h-CS during the same conditions. Two binding sites on BMP-2 for the GAG 
heparin have been suggested178 and a similar interaction with CS could be likely. For 
other GAG-proteins systems, like HA and the dimer TSG-6, a cross-linking behavior 
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has been seen.122 Whether the interaction between BMP-2 and CS is of a cross-linking 
nature or if the CS chain accommodates itself in a binding pocket of BMP-2179 is too 
early to say. 
 
The effect of introduced functional groups on GAGs on protein interactions was 
further investigated in Paper II. The GAGs CS and HA, having biotin groups 
differently placed on the chains, were immobilized to a SA-presenting SAM 
(section 7.3.2) and degradation caused by the enzyme hyaluronidase was studies using 
QCM-D.  
 
 
Figure 25. Normalized QCM-D frequency and dissipation signals when adding hyaluronidase 
I (pH 5.8) to biotinylated HA immobilized to a SA-SAM, b-HA 4.3% (solid line), 
b-HA 2.6% (dashed line) and b-HA end-on (dotted line). Degradation is seen as an increase 
in frequency and a decrease in dissipation. After the addition of hyaluronidase I the flow was 
stopped for 1 h with 2–3 intermediate pulses to introduce fresh enzyme. 
When biotinylation was made side-on, along the HA chain, HA was not properly 
recognized by hyaluronidase and a low degradation was seen. The degradation 
decreased as the degree of biotinylation increased. However, end-on biotinylated HA 
was degraded to about 80% (Figure 25). The surface-based experiments were 
compared to bulk degradation of the same derivatives by hyaluronidase, studied using 
high performance liquid chromatography (HPLC). The results were the same, 
showing that the differences between the GAG derivatives are in fact due to 
functionalization rather than to surface immobilization. 
 
Hyaluronidase could serve as a cheap probe to evaluate biofunctionality of surface 
immobilized GAGs before using more expensive proteins. Obviously, the relevance 
will depend on where on the GAG this protein is expected to bind. Hyaluronidase 
cleaves the β-1,4-glycosidic bond in HA and CS under acidic conditions, yielding 
tetra-or hexasaccharide products.180-182 For side-on biotinylated derivatives, biotin 
groups are present on the carboxylic group on C6’, close to the β-1,4-glycosidic bond, 
likely obstructing the action of hyaluronidase (Table 1). 
 
An example of a GAG interaction resulting in larger supramolecular structures is the 
interaction between HA and aggrecan, illustrated in Figure 1. Aggrecan is a large 
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proteoglycan (∼2.75 MDa183) consisting of a protein core with numerous CS and KS 
chains extending from it in a bottle-brush structure. Multiple aggrecan molecules can 
bind along the side of HA together with a link protein, building highly hydrated 
assemblies that are important for the pressure resistance of cartilage.44 Here, the 
interaction between HA and aggrecan was studied using the QCM-D technique, 
experiments that also emphasized the influence of GAG-biotinylation. HA was either 
biotinylated along the HA chain and immobilized to an SA-SAM (section 7.3.2), or 
left non-functionalized and immobilized to a SLB-NH2 (section 7.3.1). Aggrecan 
binding was higher to non-functionalized HA and low binding was seen to 
biotinylated HA (Figure 26). Since the amount of surface-bound HA depended on the 
immobilization method, aggrecan binding was normalized to the extent of HA 
immobilization. Saturation of the HA-surface was not reached with the experimental 
conditions used here, but values were taken after 10 min of aggrecan binding. 
 
 
Figure 26. Normalized QCM-D frequency response after 10 min of aggrecan binding 
(10 µg/ml in PBS pH 7.4) to biotinylated HA (HA 4.3%) side-on immobilized to a SA-SAM and 
to non-functionalized HA side-on immobilized to SLB-NH2 55%. 
7.4.2 Side-­‐on	  vs.	  end-­‐on	  immobilization	  (Paper	  II,	  additional	  results)	  
The interaction between HA and aggrecan, mentioned above, also highlighted the 
influence of the configuration of the GAG on the surface, apart from the presence of 
functional groups. Although an end-on configuration of GAGs seemed like a 
promising strategy, the binding of aggrecan was hardly detectable to HA immobilized 
in this way, compared to when non-functionalized HA was immobilized in a side-on 
configuration (Figure 27, Figure 28). 
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Figure 27. Normalized QCM-D frequency response after 10 min of aggrecan binding 
(10ug/ml in PBS pH 7.4) to end-on biotinylated HA (b-HA) displaying full or half coverage, 
biotinylated HA (HA 4.3%) side-on immobilized to a SA-SAM and to non-functionalized HA 
side-on immobilized to SLB-NH2 55%. The rightmost bar is repeated from Figure 26. 
 
Figure 28. QCM-D frequency (blue) and dissipation (red) signals for a 10 min addition of 
aggrecan (10 µg/ml in PBS pH 7.4) to a) non-functionalized HA side-on immobilized to SLB-
NH2 55% and b) end-on biotinylated HA (b-HA) immobilized to SAM-SA (full coverage). The 
responses are shown for both the 1st (lighter colours) and 7th (darker colours) harmonic. The 
QCM-D response is normalized to the QCM-D frequency response for HA: 18 and 28 Hz, 
respectively.  
However, several factors have to be taken into consideration when viewing these 
results. The HA chains used here are very short compared to HA in vivo (15-23 kDa 
compared to a few million Da), forming a, in comparison, closed-packed structure 
when immobilized in the end-on configuration. Based on measurements in SPR, a 
saturated surface of b-HA has a chain-to-chain distance of ∼14 nm (Table 3). The CS 
chains of aggrecan extends ∼30 nm out from the core protein,184 hence the 
chain-to-chain distance is not enough to accommodate aggrecan in between the chains. 
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A lower coverage increased the binding but even here the chain-to-chain distance 
(∼30 nm) is smaller than the width of aggrecan. However, similar responses to the 
ones seen in Figure 28 have been reported recently, even though longer b-HA chains 
(∼1 MDa) having a lower surfaces density, as well as a higher aggrecan concentration, 
were used.185 As multiple copies of aggrecan can bind to the side of the HA chain, the 
side-on configuration of HA likely presents the molecules in a more accessible 
configuration. Aggrecan is a very large molecule, having a length of ∼350 nm.184 The 
sensing depths of QCM-D is ∼250 nm in water,151,186 hence, even a monolayer of 
aggrecan molecules in an end-on configuration on the QCM-D sensor, could partly 
extend outside the sensing depth and could be an additional explanation to the low 
values seen. It is interesting to note that in vivo, aggrecan molecules are likely packed 
very densely along the HA chain; measurements of 1 aggrecan molecule per 30 nm 
(on average) have been reported.44 
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7.5 Biological	  applications	  of	  surface	  immobilized	  
glycosaminoglycans	  
7.5.1 Binding	  of	  herpes	  simplex	  virus	  glycoprotein	  C	  (Paper	  III)	  
As discussed in section 3.3, many viruses use GAGs on proteoglycans on cell surfaces 
as attachment factors to enable viral entry into to the cell and eventually spreading of 
the virus. For example, glycoprotein C (gC) on the herpes simplex virus (HSV) is 
known to interact with sulfated GAGs.74,75 This glycoprotein, as well as other GAG-
binding glycoproteins, has a mucin-like region rich in glycosylation (Figure 29). This 
region is known to be important in regulating the immune response from the host cell, 
as they either cause recognition or evasion of the virus from the immune system.187-189 
Less is however known about how this region influences the binding of viral 
glycoproteins to GAGs. In Paper III, we investigated how native HSV gC differed in 
its binding to sulfated GAGs, compared to a mutated version, gCΔmuc85 that lacked 
the mucin-like region (Figure 29). 
 
 
Figure 29. Schematic illustration of a HSV virion and a) native gC and b) the mutated version 
gCΔmuc. The gC includes a transmembrane region (bottom), loops caused by disulfide 
bridges, a positively charged GAG-binding region close to the mucin-like region consisting of 
numerous N-glycans (red) and O-linked glycans (green). 
Binding of the two gC variants to non-sulfated b-HA, naturally sulfated b-CS, and 
synthetically sulfated b-sHA (Table 2) were probed using SPR-based sensing. 
Equilibrium binding curves were fitted to Eq.	  6 to obtain binding parameters (Figure 
30). 
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Figure 30. a) Representative equilibrium binding curves (symbols) fitted to Eq. 6 (lines) for 
native gC and gCΔmuc. The binding is normalized to the SPR response of GAGs on the 
surface. b) Binding parameters from the fitted curves in a). 
 
 
 
 
 
Figure 31. Normalized dissociation of native gC (dashed curve) and gCΔmuc (solid curve) 
from b-CS. A double exponential equation was required for a good fit of the native gC 
dissociation. 
  
GAG
K0.5 [nM] n no. of gC/GAG
gC(KOSc) gC(AC1) gC(KOSc) gC(AC1) gC(KOSc) gC(AC1)
CS 5.3 ± 0.6 47.7 ± 11.2 1 ± 0.5 1.6 ± 0.1 1.0 ± 0.4 16.5 ± 5.8
sHA 4.9 ± 0.04 66.3 ± 10.1 1.9 ± 0.3 1.9 ± 0.4 1.5 ± 0.3 14.6 ± 2.7
a)
b)
wild-type gC gC∆muc
K0.5
K0.5
K0.5
K0.5
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As expected, gCs bound preferably to the sulfated GAGs b-CS and b-sHA compared 
to non-sulfated b-HA. gCΔmuc, where the mucin-like region is deleted, had a lower 
affinity for the sulfated GAGs (Figure 30). However it also exhibited a slower 
dissociation (Figure 31), indicating that once formed, the interaction between 
gCΔmuc and sulfated GAGs is more stable than for native gC. The number of gC 
proteins that bound per GAG chain, calculated from the maximal gC binding 
estimated from Eq.	  6, was significantly higher for gCΔmuc compared to native gC. 
Without the negatively charged mucin-like region, the gC is smaller and there is likely 
less repulsion between the gC and the GAGs as well as between gC copies, allowing 
them to pack more closely.  
 
Interestingly, there was no significant difference between the two sulfated GAGs 
b-CS and b-sHA for either gC variant. CS and sHA differ in length, degree of 
sulfation and surface density (Table 2, Table 3) resulting in an order of magnitude 
higher surface density of sulfate groups. The synthetic sulfation of b-sHA occurs 
randomly whereas b-CS (CS-A/CS-C) has a more defined pattern (Table 1). This 
suggests that the positioning of sulfation groups on the disaccharide or along the GAG 
chain, rather than mere presence, is important in promoting gC binding. Also, the 
need for disulfated repeating units as a requirement for gC binding, which has been 
suggested by others,190 was not supported in this study, as b-CS has no disulfated 
units. 
 
In Paper III, the observation from the gC-binding studies was compared to cell 
studies with two virus strains carrying the different gC, KOS and KOS-gCΔmuc 
respectively. It was seen that KOS-gCΔmuc had a lower affinity to heparin and a 
shorter GAG-mimetic. Also, KOS-gCΔmuc particles seemed to be trapped on the 
surface of the cells. These results together suggest that the mucin-like region is not 
required for binding but rather has a modulating function, enabling release of the gC 
from the GAG and potentially also the virus from the cell surface. A tuned binding, 
but also unbinding, of viruses to cells is crucial for an efficient infectious cycle in 
order to avoid non-productive binding events where the virus is trapped instead of 
infecting the cell. 
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7.5.2 Initial	  effect	  of	  chondrocytes	  (Paper	  IV)	  
As discussed in section 3.2.4, HA is a common starting material for the construction 
of tissue scaffolds, used in, e.g., bone and cartilage applications. In Paper IV, human 
derived chondrocytes were added in serum-free media to b-HA immobilized to a SA-
presenting SAM (section 7.3.2). The response from the added cells was studied under 
stagnant conditions for ~140 min before rinsing, using the QCM-D technique 
combined with light microscopy. As opposed to when adding chondrocytes to 
polystyrene (Figure 32, grey line), a commonly used cell culture material, addition of 
chondrocytes to b-HA induced an increase in frequency and a decrease in dissipation, 
indicating loss of material (Figure 32, black line). Light microscopy images taken of 
the b-HA modified surface show present, but non-attached chondrocytes, which are 
removed upon rinsing. In the case of polystyrene, attachment was observed. The 
combined results from the two techniques suggest that the chondrocytes do not bind 
to the b-HA, but rather that the GAG layer may be degraded in the presence of the 
chondrocytes, most likely by released enzymes. The change in the frequency and 
dissipation signals corresponds to ∼90% of the signals for the HA-layer, and indicates 
a degradation comparable to that seen for hyaluronidase in Paper II. 
 
Figure 32. a) QCM-D frequency and dissipation signals for the addition of chondrocytes to 
polystyrene (grey) or to b-HA immobilized on a SA-presenting SAM (black). Addition of cells 
on both surfaces is set to zero, marked by a red arrow. Black arrows mark the prior additions 
of SA and b-HA. b) light microscopy images taken during the QCM-D experiment for the two 
surfaces at given time points. Scale bar is 100 µm. 
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The degradation response is fast, suggesting that the active substance is already 
present at the cell surface, or within the cell and released upon contact. One should 
note that the underlying HA-layer is expected to be very thin compared to the size of 
the chondrocyte (HA length ∼60 nm vs. cell ∅ ∼20 µm), and markedly different from, 
e.g., a HA-based scaffold, usually consisting of longer chains with extensive 
functionalization and/or crosslinking (section 3.2.4). 
 
The occurrence of HA in cartilage in vivo is regulated by the expression of 
synthesizing enzymes (HA synthase) and degrading enzymes (hyaluronidases).51 The 
primary route of HA degradation by chondrocytes occurs via CD44-mediated 
endocytosis, and later degradation in lysosomes within the cell.191 However, the 
occurrence of lower molecular weight HA in the ECM suggests the presence of an 
extracellular degradation of HA as well.51 The internalization of HA for degradation 
has been shown to be dependent of the molecular weight of HA; large HA molecules, 
or HA associated with aggrecan seems too large to be endocytosed.192 It is easy to see 
how extracellular and lysosomal degradation could work in concert, degrading larger 
and smaller HA molecules and assemblies, respectively. An enzyme similar to PH-20, 
which is a membrane associated hyaluronidase active at neutral pH, has been found to 
be expressed and secreted by chondrocytes,193 and might be a candidate for the effect 
seen here. 
 
Even though additional experiments would be required to draw more precise 
biological conclusions, the study shows that the combination of QCM-D and light 
microscopy can be used to monitor changes in the interface between a material 
surface and a cell, even in the absence of cell attachment. The QCM-D technique is 
increasingly used in cell research, studying attachment as well as conformational 
changes.194-198  
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7.5.3 Interactions	  with	  bone	  morphogenetic	  protein	  2	  (additional	  results)	  
As discussed in section 3.2.1, the growth factor bone morphogenetic protein 2 
(BMP-2) binds to GAGs, which could potentially offer a strategy to modulate the 
effect of BMP-2 in vitro and in vivo. However, both inhibitory199,200 and 
promoting178,201,202 effects of GAGs on BMP-2 interactions and cell-signaling has 
been presented in the literature. Hence the mechanisms behind the effect of GAG-
growth factor binding are not fully understood. It is likely to be dependent on many 
factors, such as GAG length and sulfation pattern, as well as administered dosage and 
timing. 
 
To complement the results in Paper I, where the binding of BMP-2 to side-on 
immobilized CS was studied, the same interaction was probed using end-on 
immobilized GAGs (section 7.3.2). Preliminary results are summarized in Figure 33.  
 
 
Figure 33. a) Example SPR curves showing binding of rhBMP-2 (in PBS at pH 7.4, using a 
series of concentrations; 0.5, 2.5, 5, 10, and 15 µg/mL) to immobilized b-CS (solid) and b-HA 
(dashed) as well as to the SA background (grey). b) The corresponding saturation values 
obtained for immobilized b-CS (squares, n=2 for the lower concentrations) and b-sHA (circles, 
n=2 for the highest concentration). The SPR responses are normalized to the SPR response 
for the corresponding GAG-layer. 
Significant binding was only seen to the sulfated GAGs b-CS and b-sHA; the binding 
to non-sulfated b-HA was as low as to the SA background, which emphasize the 
importance of sulfation in this interaction. Although not complete at this stage, 
equilibrium binding curves suggest a higher affinity of BMP-2 to b-sHA (Figure 33b), 
which is in line with other studies where an increased degree of sulfation induced 
higher affinity for the binding growth factors BMP-2199 and BMP-429. However, in 
contrast to the mentioned studies, significant binding was seen already to the lower 
sulfated b-CS in our experiments (b-CS: DSsulfate=0.9 vs. b-sHA: DSsulfate=3.1, Table 
2). This suggests a possible importance of sulfation of the C6 position, as this is 
partially sulfated in b-CS, and fully sulfated in b-sHA (Table 1).29,201 
 
a) b)
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The affinity that can be expected from the curves in Figure 33 is significantly smaller 
than what was reported previously for binding of BMP-2 to surface-immobilized 
heparin during physiological conditions (0.5 µg/mL or 20 nM).178 This could be due 
to a difference in the BMP-2 batches or in the immobilization. In the mentioned study, 
a stoichiometric ratio of 5-6 BMP-2 molecules/ heparin chain (16 kDa) was estimated 
at maximal saturation (at 5 µg/mL (200 nM)). In our study, the highest stoichiometric 
ratio measured was 9 BMP-2 molecules/ b-CS chain at 90 µg/mL (3.5 µM). The fact 
that b-CS is 25% longer than the heparin used could explain why more BMP-2 
proteins were accommodated. However, the solubility of BMP-2 is likely affected at 
these high concentrations, hence these values should be interpreted with caution. The 
grafting density of GAGs on the surface was not varied in our experiments, but is 
likely to have an effect on the number of BMP-2 molecules than could bind along one 
GAG chain. The grafting density used here (∼20 nm between immobilized GAGs) 
should leave space for the homodimeric BMP-2 molecule (7x3.5x2.5 nm) as 
suggested by molecular modeling.179 
 
The low binding seen to SA and b-HA was confirmed in measurements using the 
QCM-D technique. Furthermore, binding of BMP-2 to b-CS and b-sHA seemed to 
result in a condensation of the layers, as the ΔD/Δf ratio decreased when the growth 
factor was added. This is in line with what was seen for BMP-2 binding to h-CS 
immobilized in a side-on configuration in Paper I (section 7.4.1). 
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Perspectives	  and	  outlook	  
The aim of this thesis project was to study GAG-related interactions using 
surface-based analytical techniques. This approach relies on controlled 
immobilization of GAGs to surfaces. It is important to note that to study how GAGs 
alone participate in an interaction is a simplification from the in vivo state, as most 
GAGs are linked to a proteoglycan core protein. Although an interesting strategy, 
immobilization of a whole proteoglycan would increase the potential variations in the 
molecular structure greatly. The strategy chosen here allows for detailed studies of 
how GAGs with different properties interact with various entities, rendering 
information that would likely be obscured in more complex systems using whole 
proteoglycans. 
 
To ensure reliable results from an interaction study, the immobilization strategy must 
not affect the interacting biomolecules. Two aspects of surface immobilization of 
GAGs were highlighted in this thesis project: i) the presence of introduced functional 
groups on the chain, and ii) the orientation of the GAG on the surface, controlled by 
the position of the surface attachment point. Functional groups introduced along the 
GAG chain were shown to influence subsequent interactions. To avoid this, and to 
better mimic the attachment of GAGs to a core protein, immobilization via the 
reducing end of the GAG by biotin-streptavidin binding was chosen as a preferred 
strategy for further interaction studies. Even though the end-on immobilization 
strategy has obvious benefits, the density of GAGs on the surface and the length of 
the GAG chains are two important aspects, where the optimal surface will depend on 
characteristics, e.g., size, of the interacting entity. A layer-by-layer assembly is 
another immobilization example were introduced functional groups are avoided, but 
where the GAG is complemented by the presence of a positively charged polymer. 
 
The usefulness of the interaction platform was further assessed by studying the 
binding behavior of glycoprotein C, purified from herpes simplex virus type 1 
(HSV-1). The presence of a highly glycosylated, mucin-like region, with a previously 
unclear function in binding, was shown to modulate the binding of the glycoprotein to 
the GAG. This likely has implications for the infectious mechanism of the virus, 
further suggested by cell studies, where attachment of virions having glycoproteins 
either with, or without this region, was compared. The binding of whole viruses to 
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end-on immobilized GAGs is currently being investigated using total internal 
reflection fluorescence (TIRF) microscopy, where the binding and unbinding of 
viruses are being probed in order to estimate kinetic parameters. In line with what has 
been presented herein, virions did not bind to non-sulfated HA but significantly to 
sulfated GAGs (Figure 34). To compare binding of different virus strains to GAGs 
using this setup can complement common cell-binding assays, and could potentially 
also be used to study the lateral movement of viruses on a surface. 
 
 
Figure 34. HSV-1 virions binding to a,b,c) b-HA and d,e,f) b-CS, immobilized to biotinylated 
SLBs (99% POPC + 1% DOPE-biotin). a, b) TIRF images showing fluorescently labeled 
HSV-1 virions bound to the surface. b,c,e,f) Counting the number of virus that bind and 
unbind can give information about kinetic characteristics. Work in progress: Peerboom, 
Altgärde, Trybala, Bergström, Bally et al. 
The sulfation of GAGs is an aspect often discussed in literature as being a determinant 
in many binding events. In this thesis project, non-sulfated b-HA and two sulfated 
GAGs; the naturally sulfated b-CS and the synthetically sulfated b-sHA were used. 
For both virus glycoprotein and BMP-2, sulfation was a requisite for binding as very 
low binding was seen to b-HA in either case. Differences between b-CS and b-sHA 
was not as significant, indicating that either the need for specific patterns of sulfate 
groups are not pronounced for these proteins, or that the required GAG sequence is 
present in both the b-CS and the b-sHA used here. Further interaction studies, along 
with successful molecular sequencing and de novo synthesis of GAGs, are needed in 
order to find sequence-specific effects. This is also a prerequisite for the development 
of GAG-based drugs. As GAGs have a multitude of functions in vivo, isolation of the 
active sequence is needed to avoid cross-reactions and unwanted side effects. An 
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example of this is the anticoagulant drug heparin, which today is administered as a 
depolymerized variant or as a synthesized pentasaccharide. 
 
In this thesis project, QCM-D and SPR were the main surface sensitive techniques. 
The benefits of using both of these techniques when measuring the formation of GAG 
layers are apparent when looking at the significant hydration of these molecules. The 
interface between immobilized hyaluronan and chondrocytes was studied using 
QCM-D in combination with light microscopy. The study suggested a degrading 
action of the cells on the underlying layer, and showed, more importantly, that the 
interface between cells and biomaterials can be studied using surface sensitive 
techniques even when cell attachment does not occur. To develop this approach 
further, growth factors, e.g., BMP-2 could be added to probe possible changes in the 
cell. Also, immobilized hyaluronan derivatives with a higher molecular weight, with 
and without in situ cross-linking, could better resemble scaffolds used in many in vivo 
applications. 
 
Hopefully, this thesis project has emphasized the importance of GAGs in many 
biological mechanisms, and the kind of information that can be gained from studying 
them using surface-based analytical techniques. The use of such techniques to study 
GAG-based interactions is not new, but the immobilizing strategy and how it may 
influence the studied interaction is seldom regarded or discussed. The studies 
presented here highlight important factors to consider when designing GAG-
presenting surfaces, to further unravel the functions and possibilities of GAGs in vivo 
and in vitro. 
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